AceView offers a comprehensive annotation of human, mouse and nematode genes
reconstructed by co-alignment and clustering of all publicly available
mRNAs and ESTs on the genome sequence. Our goals are to offer a reliable
up-to-date resource on the genes, their functions, alternative variants,
expression, regulation and interactions, in the hope to stimulate
further validating experiments at the bench
This site normally requires a frame enabled viewer,
However, click here to access our full description of gene STARD10andARAP1.
, go to our main page or see our latest news
Homo sapiens complex locus STARD10andARAP1, encoding centaurin delta 2 CRA d family member.
TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Compact gene diagram
Alternative mRNAs are shown aligned from 5' to 3' on a virtual genome where introns have been shrunk to a minimal length. Exon size is proportional to length, intron height reflects the number of cDNAs supporting each intron. Introns of the same color are identical, of different colors are different. 'Good proteins' are pink, partial or not-good proteins are yellow, uORFs are green. 5' cap or3' poly A flags show completeness of the transcript.
Read more...
Mouse over the ending of each transcript gives tissues from which the supporting cDNAs were extracted. Details on tissue of origin for each intron and exon is available from the
intron and exons table.
Click on any transcript to open the specific mRNA page, to see the exact cDNA clone support and eventual SNPs and to get details on tissues, sequences, mRNA and protein annotations. Proteins supported by a single continuous cDNA sequence lead to underlining the name/ending of the variant. Names not underlined result from cDNA concatenation in the coding region and should be experimentally checked.
Introns are depicted by broken lines; the height of the top of each intron reflects the relative number of clones supporting this intron.
]^[ A pink broken line denotes an intron with standard boundaries (gt-ag or gc-ag) that is exactly supported (i.e. a cDNA sequence exactly matches the genome over 16 bp, 8 on both sides of the intron).
] ^ ] A blue broken line denotes non-standard introns, exactly supported, but with non-standard at-ac or any other boundaries.
]-[ Pink and
] - ] blue straight lines represent 'fuzzy' introns of the standard and non-standard types respectively, those introns do not follow the 16 bp rule. Black straight lines ]-[denote gaps in the alignments.
Exons: Wide filled pink areas represent putative protein coding regions, narrow empty pink boxes represent the 5'UTR (on the left) and 3' UTR (on the right). Flags identify validated endings: cap site on the 5' side, polyadenylation site on the 3' side. Filled flags correspond to frequent events while empty flags have lesser supporting cDNAs (yet all are validated); at the 3' side, black flags are associated to the main AATAAA signal,
blue flags to any single letter variant of the main . More explanations are given in the
gene help file
Expression and GenBank cDNA support
Tissues where expression was observed (from 755 cDNA clones)
Origin of the cDNAs, as reported in GenBank/dbEST (tissue, stage, pathological or normal) shows that the gene is expressed in brain (seen 61 times), testis (32), pancreas (30), placenta (29), colon (27), eye (27), stomach (26), uterus (26), lung (23), breast (17), medulla (15), prostate (15), purified pancreatic islet (15), skin (13), kidney (12), lymph (11), marrow (11), placenta cot 25-normalized (11), adenocarcinoma (10), ovary (10), 2 pooled tumors (clear cell type) (8), adenocarcinoma cell line (8), anaplastic oligodendroglioma (8), cell lines (8), chondrosarcoma (8), uterus tumor (8), anaplastic oligodendroglioma with 1p/19qloss (7), colon normal (7), leukocyte (7), liver (7), melanotic melanoma (7), pooled lung and spleen (7), ascites (6), islets of langerhans (6), kidney tumor (6), normal pigmented retinal epithelium (6), pooled germ cell tumors (6), hippocampus (5), metastatic chondrosarcoma (5), optic nerve (5), pancreatic islet (5), stroma (5), whole brain (5), alveolar macrophage (4), carcinoma, cell line (4), caudate nucleus (4), cerebellum (4), cervix (4), colon ins (4), fetal brain (4), fetal eyes, lens, eye anterior segment,optic nerve, retina, retina foveal and macular, RPE andchoroid (4), head neck (4), liver and spleen (4), lung tumor (4), lymphoma, cell line (4), ovarian tumor (4), parathyroid gland (4), parathyroid tumor (4), pooled human melanocyte, fetal heart, andpregnant uterus (4), pooled pancreas and spleen (4), poorly differentiated adenocarcinoma withsignet ring cell features (4), b-cells (3), blood (3), choriocarcinoma (3), embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells (3), germinal center B cell (3), head normal (3), hepatocellular carcinoma, cell line (3), hypothalamus (3), leiomyosarcoma (3), lens (3), lymph node (3), melanotic melanoma, cell line (3), moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors (3), nervous tumor (3), neuroblastoma (3), neuroblastoma cot 25-normalized (3), pectoral muscle (after mastectomy) (3), primary b-cells from tonsils (cell line) (3), primary lung cystic fibrosis epithelialcells (3), serous papillary carcinoma, high grade, 2pooled tumors (3), small cell carcinoma (3), small intestine (3), spleen (3), teratocarcinoma, cell line (3), adrenal cortex carcinoma, cell line (2), adrenal gland (2), b-cell, chronic lymphotic leukemia (2), brain, adult medulla (2), brain, cerebellum, PCR rescued clones (2), carcinoid (2), colon tumor, RER+ (2), embryonic stem cells, cell lines H1, H7, andh9 (2), epid tumor (2), epithelioid carcinoma cell line (2), eyeball (2), heart (2), human embryonic stem cells (2), iris (2), left pelvis (2), leiomyosarcoma cell line (2), lung normal (2), lymphoma, follicular mixed small and largecell (2), melanocyte (2), natural killer cells, cell line (2), neuroblastoma cot 50-normalized (2), pituitary (2), pooled colon, kidney, stomach (2), squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) (2), synovial membrane tissue from rheumatioidarthritis (2), uterus, leiomyosarcoma (2), well-differentiated endometrialadenocarcinoma, 7 pooled tumors (2), 2 pooled wilms' tumors, one primary and onemetastatic to brain (once), adipose (once), alzheimer cortex (once), amygdala (once), astrocytoma grade IV, cell line (once), aveolar macrophage (once), bladder (once), blastocyst (once), bone (once), brain, neuroblastoma (once), breast normal (once), chondrosarcoma grade II (once), CNCAP(3)T-225 cell line (once), colonic mucosa from 3 patients with crohn'sdisease (once), colon est (once), colorectal carcinoma (once), corpus callosum (once), dorsal root ganglia (once), duodenal adenocarcinoma, cell line (once), embryonic stem cell, retinoic acid andmitogen-treated hes cell line H7 (once), enchondroma (once), epididymis (once), fetal liver (once), fibrotheoma (once), four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary (once), glioblastoma (pooled) (once), glioblastoma with EGFR amplification (once), human retina (once), hypernephroma (once), hypernephroma, cell line (once), kidney, tumor tissue (once), lacrimal gland (once), leukopheresis (once), lymphocyte (once), malignant melanoma, metastatic to lymphnode (once), mammary gland (once), melanoma (mewo cell line) (once), melanotic melanoma, high MDR (cell line) (once), moderately differentiated adenocarcinoma (once), normal endometrium, mid-secretory phase,cycle day 23 (once), normal prostate (once), pancreas, epithelioid carcinoma (once), pineal gland (once), placenta, choriocarcinoma (once), placenta normal (once), pluripotent cell line derived fromblastocyst inner cell mass (once), primary lung epithelial cells (once), pterygium (once), retinoblastoma (once), RPE and choroid (once), rpe/choroid (once), squamous cell carcinoma (once), stomach normal (once), subchondral bone (once), substantia nigra (once), sympathetic trunk (once), t-lymphocytes (once), thalamus (once), thymus (once), thyroid gland (once), transitional cell papilloma, cell line (once), tumor, 5 pooled (see description) (once).
755 cDNA clones support the 40 variants of gene STARD10andARAP1
?
This table helps analyze the pattern of expression of the gene, the tissue, cell type or disease state specificity of the alternative variants and to select cDNA clones suitable for your experiments.
cDNA accession Links to the sequence |
Tissue
most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features |
Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
CV816232 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 1 to 833 | 1 to 840 | | tiling clone, | | 840/886 (94 %) | 25 diff (97.2 %id) |
AY553630 | | .a | 3 to 5141 | 8 to 5146 | exact | tiling clone, | | 5139/5146 (99 %) | 5 diff (100.0 %id) |
NM_001040118.2 | | .a | 11 to 5146 | 1 to 5136 | exact | RefSeq, AAA | | 5136/5136 (100 %) | 0 diff (100 %id) |
TI_154152079 | | .a | 11 to 559 | 80 to 629 | | | | 550/550 (100 %) | 14 diff (97.5 %id) |
CN287102 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 39 to 499 | 1 to 461 | | | | 461/461 (100 %) | 0 diff (100 %id) |
AW505063 | lymph | .a | 72 to 271 | 18 to 217 | | | | 200/217 (92 %) | 6 diff (97.3 %id) |
AJ621557 | | .a | 200 to 4552 | 1 to 4353 | exact | | | 4353/4353 (100 %) | 0 diff (100 %id) |
AF411983 | | .a | 1142 to 4552 | 1 to 3411 | | | | 3411/3411 (100 %) | 0 diff (100 %id) |
AW503605 | lymph | .a | 2834 to 3300 | 90 to 556 | | | | 467/556 (83 %) | 9 diff (98.4 %id) |
BQ065379 | lymph, lymphoma, cell line | .a | 3419 to 4322 | 1 to 912 | | | | 912/1030 (88 %) | 14 diff (98.7 %id) |
R13131 | whole brain | .a | 3494 to 3868 | 1 to 386 | | | | 386/395 (97 %) | 21 diff (94.7 %id) |
BG824241 | adenocarcinoma cell line, colon | .a | 3556 to 4322 | 1 to 774 | | | | 774/777 (99 %) | 8 diff (99.0 %id) |
BG756653 | B-cells, primary B-cells from tonsils (cell line) | .a | 3776 to 4605 | 1 to 830 | | | | 830/830 (100 %) | 5 diff (99.4 %id) |
BY996734 | | .a | 3788 to 4484 | 18 to 714 | | | | 697/714 (97 %) | 6 diff (99.2 %id) |
BI834233 | pooled pancreas and spleen | .a | 3789 to 4670 | 1 to 885 | | | | 883/885 (99 %) | 16 diff (98.2 %id) |
TI_57163694 | | .a | 3789 to 4670 | 34 to 918 | | | | 883/918 (96 %) | 21 diff (97.8 %id) |
BU182811 | melanotic melanoma, skin | .a | 3850 to 4637 | 1 to 791 | | | | 791/819 (96 %) | 14 diff (98.3 %id) |
AV724261 | hypothalamus | .a | 3932 to 4640 | 1 to 699 | | | | 699/700 (99 %) | 26 diff (96.3 %id) |
CD626851 | | .a | 3967 to 4527 | 8 to 570 | | | | 563/582 (96 %) | 10 diff (98.3 %id) |
CD626852 | | .a | 3967 to 4527 | 569 to 7 | | | | 563/576 (97 %) | 0 diff (100 %id) |
BQ379179 | uterus_tumor | .a | 4108 to 4388 | 285 to 3 | | | | 283/289 (97 %) | 12 diff (95.9 %id) |
BG679332 | skin, squamous cell carcinoma | .a | 4153 to 4928 | 1 to 776 | | | | 776/777 (99 %) | 7 diff (99.1 %id) |
BE696651 | colon | .a | 4270 to 4660 | 18 to 414 | | | | 395/414 (95 %) | 20 diff (95.2 %id) |
CN350992 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 4270 to 4843 | 1 to 574 | | | | 574/574 (100 %) | 2 diff (99.7 %id) |
TI_149315647 | | .a | 4273 to 5146 | 951 to 87 | | AAA | | 868/981 (88 %) | 16 diff (98.4 %id) |
AW798258 | uterus | .a | 4313 to 4619 | 326 to 20 | | | | 307/326 (94 %) | 1 diff (99.7 %id) |
BI519567 | leukocyte | .a | 4317 to 5091 | 833 to 4 | | | | 737/959 (76 %) | 64 diff (93.4 %id) |
TI_44459549 | | .a | 4317 to 5091 | 833 to 4 | | | | 737/959 (76 %) | 64 diff (93.4 %id) |
TI_149313986 | | .a | 4317 to 5141 | 907 to 84 | | AAA | | 824/990 (83 %) | 11 diff (98.9 %id) |
TI_149278331 | | .a | 4320 to 5146 | 907 to 85 | | AAA | | 823/1111 (74 %) | 18 diff (98.4 %id) |
BM713933 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 4320 to 4928 | 1 to 609 | | | | 609/610 (99 %) | 1 diff (99.9 %id) |
BI117870 | lung, small cell carcinoma | .a | 4350 to 5083 | 1 to 745 | | | | 745/912 (81 %) | 41 diff (95.6 %id) |
AW869166 | stomach_normal | .a | 4360 to 4623 | 276 to 3 | | | | 270/277 (97 %) | 13 diff (95.4 %id) |
CD370274 | Alveolar Macrophage, lung | .a | 4374 to 5141 | 786 to 19 | | AAA | | 768/768 (100 %) | 11 diff (98.6 %id) |
CB305796 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 4379 to 5141 | 782 to 19 | | AAA | | 764/764 (100 %) | 2 diff (99.8 %id) |
H45750 | breast | .a | 4381 to 4791 | 1 to 422 | | fully sequenced, | | 422/422 (100 %) | 20 diff (95.3 %id) |
CD742934 | Alveolar Macrophage, lung | .a | 4382 to 5141 | 779 to 19 | | AAA | | 761/764 (99 %) | 3 diff (99.7 %id) |
BF527874 | anaplastic oligodendroglioma with 1p/19qloss, brain | .a | 4394 to 5143 | 1 to 746 | | | | 746/765 (97 %) | 11 diff (98.6 %id) |
AA285118 | ovarian tumor, ovary | .a | 4401 to 4734 | 1 to 331 | | fully sequenced, | | 331/331 (100 %) | 5 diff (98.5 %id) |
CR746126 | | .a | 4423 to 4698 | 1 to 276 | | | | 276/276 (100 %) | 1 diff (99.7 %id) |
BU633165 | cell lines, Chondrosarcoma | .a | 4453 to 5141 | 707 to 19 | | AAA | | 689/689 (100 %) | 2 diff (99.8 %id) |
CA306660 | Alveolar Macrophage, lung | .a | 4454 to 5141 | 707 to 19 | | AAA | | 689/689 (100 %) | 5 diff (99.3 %id) |
C00276 | | .a | 4465 to 4735 | 1 to 275 | | | | 275/289 (95 %) | 7 diff (97.6 %id) |
R48895 | breast | .a | 4465 to 4752 | 1 to 288 | | fully sequenced, | | 288/288 (100 %) | 4 diff (98.7 %id) |
AA464114 | ovarian tumor, ovary | .a | 4488 to 4763 | 1 to 275 | | fully sequenced, | | 275/275 (100 %) | 1 diff (99.7 %id) |
BF968102 | adrenal cortex carcinoma, cell line, adrenal gland | .a | 4496 to 5145 | 1 to 654 | | | | 654/674 (97 %) | 5 diff (99.3 %id) |
BU678411 | lung | .a | 4516 to 5146 | 648 to 19 | | AAA | | 630/630 (100 %) | 2 diff (99.7 %id) |
AV753501 | Pituitary | .a | 4520 to 5143 | 1 to 624 | | | | 624/941 (66 %) | 2 diff (99.8 %id) |
BU729631.
matches multiple genes | eye, optic nerve | .a | 4540 to 5141 | 621 to 19 | | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base), also hits gene duchoy | 603/603 (100 %) | 1 diff (99.9 %id) |
CD251362 | brain, Pituitary | .a | 4548 to 5146 | 19 to 616 | | AAA | | 598/616 (97 %) | 6 diff (99.1 %id) |
BQ015687 | lung, Metastatic Chondrosarcoma | .a | 4551 to 5146 | 615 to 19 | | AAA | | 597/597 (100 %) | 4 diff (99.4 %id) |
CB306438 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 4551 to 5146 | 616 to 19 | | AAA | | 598/598 (100 %) | 2 diff (99.7 %id) |
BU616338 | Bone, Subchondral Bone | .a | 4551 to 5146 | 615 to 19 | | AAA | | 597/597 (100 %) | 1 diff (99.9 %id) |
CB529230 | Aveolar Macrophage, lung | .a | 4551 to 5146 | 615 to 19 | | AAA | | 597/597 (100 %) | 1 diff (99.9 %id) |
BX376635 | Neuroblastoma Cot 50-normalized | .a | 4578 to 5144 | 1 to 566 | | | | 566/566 (100 %) | 3 diff (99.5 %id) |
BX403157 | Neuroblastoma Cot 50-normalized | .a | 4578 to 5141 | 1 to 562 | | | | 562/562 (100 %) | 18 diff (96.8 %id) |
BF928040 | nervous_tumor | .a | 4594 to 4855 | 1 to 262 | | | | 262/262 (100 %) | 0 diff (100 %id) |
BM998379 | lung, Metastatic Chondrosarcoma | .a | 4600 to 5141 | 560 to 19 | | AAA | | 542/542 (100 %) | 0 diff (100 %id) |
TI_149296965 | | .a | 4603 to 5146 | 620 to 81 | | AAA | | 540/909 (59 %) | 20 diff (97.8 %id) |
AA744387 | Prostate, stroma | .a | 4618 to 4944 | 1 to 327 | | | | 327/350 (93 %) | 13 diff (96.3 %id) |
AA744345 | Prostate, stroma | .a | 4619 to 4944 | 1 to 325 | | | | 325/357 (91 %) | 13 diff (96.4 %id) |
AA043608 | uterus | .a | 4622 to 4848 | 1 to 233 | | fully sequenced, | | 233/233 (100 %) | 4 diff (98.3 %id) |
AA745374 | Prostate, stroma | .a | 4627 to 4944 | 1 to 316 | | | | 316/348 (90 %) | 11 diff (96.9 %id) |
AA744017 | Prostate, stroma | .a | 4627 to 4944 | 1 to 315 | | | | 315/346 (91 %) | 11 diff (96.9 %id) |
CD743184 | Alveolar Macrophage, lung | .a | 4631 to 5146 | 535 to 19 | | AAA | | 517/517 (100 %) | 1 diff (99.9 %id) |
TI_151717275 | | .a | 4644 to 5141 | 661 to 163 | | AAA | | 499/1088 (45 %) | 0 diff (100 %id) |
BF526634 | brain, glioblastoma with EGFR amplification | .a | 4654 to 5141 | 1 to 485 | | AAA | | 485/485 (100 %) | 3 diff (99.4 %id) |
AA804578 | colon | .a | 4656 to 5147 | 487 to 1 | | | | 487/490 (99 %) | 8 diff (98.4 %id) |
TI_154134343 | | .a | 4656 to 5146 | 583 to 92 | | AAA | | 492/773 (63 %) | 6 diff (99.3 %id) |
BP397079 | pancreatic islet | .a | 4666 to 5146 | 1 to 483 | | | Submitted on the opposite strand | 483/483 (100 %) | 4 diff (99.2 %id) |
BM676549 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 4667 to 5141 | 493 to 19 | | AAA | | 475/475 (100 %) | 2 diff (99.6 %id) |
BU623790 | cell lines, Enchondroma | .a | 4667 to 5141 | 494 to 19 | | AAA | | 476/476 (100 %) | 1 diff (99.8 %id) |
BU629850 | cell lines, Chondrosarcoma | .a | 4667 to 5146 | 498 to 19 | | AAA | | 480/480 (100 %) | 0 diff (100 %id) |
BX413094 | brain, fetal brain | .a | 4668 to 5135 | 468 to 1 | | | | 468/468 (100 %) | 4 diff (99.2 %id) |
BP392400 | pancreatic islet | .a | 4671 to 5141 | 1 to 471 | | | Submitted on the opposite strand | 471/471 (100 %) | 1 diff (99.8 %id) |
BG231511 | blood, lymphocyte | .a | 4675 to 5140 | 466 to 1 | | | | 466/466 (100 %) | 3 diff (99.4 %id) |
AI677855 | pooled | .a | 4676 to 5142 | 473 to 7 | | | | 467/473 (98 %) | 0 diff (100 %id) |
AI066568 | pooled | .a | 4677 to 5142 | 466 to 1 | | | | 466/466 (100 %) | 0 diff (100 %id) |
CA430680 | cell lines, Chondrosarcoma | .a | 4677 to 5141 | 484 to 19 | | AAA | | 466/466 (100 %) | 1 diff (99.8 %id) |
BU630120 | cell lines, Chondrosarcoma | .a | 4679 to 5141 | 481 to 19 | | AAA | | 463/463 (100 %) | 0 diff (100 %id) |
BX115490 | whole brain | .a | 4682 to 5141 | 475 to 15 | | AAA | | 461/462 (99 %) | 2 diff (99.6 %id) |
BM126138 | Islets of Langerhans, Pancreas | .a | 4682 to 5146 | 476 to 12 | | AAA | | 465/465 (100 %) | 0 diff (100 %id) |
BU632401 | cell lines, Chondrosarcoma | .a | 4682 to 5141 | 479 to 19 | | AAA | | 461/461 (100 %) | 1 diff (99.8 %id) |
BE139619 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .a | 4683 to 5142 | 463 to 4 | | | | 460/463 (99 %) | 0 diff (100 %id) |
BM069469 | Islets of Langerhans, Pancreas | .a | 4683 to 5141 | 470 to 12 | | AAA | | 459/459 (100 %) | 3 diff (99.4 %id) |
AI969598 | malignant melanoma, metastatic to lymphnode, skin | .a | 4684 to 5146 | 464 to 1 | | | | 464/464 (100 %) | 1 diff (99.8 %id) |
CK819021 | Islets of Langerhans, Pancreas | .a | 4684 to 5146 | 474 to 12 | | AAA | | 463/463 (100 %) | 0 diff (100 %id) |
BF111458 | pooled | .a | 4690 to 5142 | 460 to 8 | | | | 453/460 (98 %) | 0 diff (100 %id) |
BP396585 | pancreatic islet | .a | 4696 to 5140 | 1 to 445 | | | Submitted on the opposite strand | 445/451 (98 %) | 1 diff (99.8 %id) |
AI343576 | 2 pooled tumors (clear cell type), Kidney | .a | 4696 to 5142 | 449 to 3 | | | | 447/449 (99 %) | 0 diff (100 %id) |
AI475509 | B-cell, chronic lymphotic leukemia | .a | 4696 to 5142 | 453 to 7 | | | | 447/453 (98 %) | 0 diff (100 %id) |
AA284961 | ovarian tumor, ovary | .a | 4704 to 5141 | 437 to 1 | | fully sequenced, | | 437/437 (100 %) | 5 diff (98.9 %id) |
AA913790 | pooled | .a | 4706 to 5142 | 434 to 3 | | | | 432/435 (99 %) | 0 diff (100 %id) |
CA433319 | mixed | .a | 4706 to 5146 | 459 to 19 | | AAA | | 441/441 (100 %) | 1 diff (99.8 %id) |
AA772496 | pineal gland | .a | 4711 to 5141 | 425 to 1 | | | | 425/425 (100 %) | 11 diff (97.5 %id) |
AA946761 | 2 pooled tumors (clear cell type), Kidney | .a | 4711 to 5142 | 430 to 3 | | | | 428/430 (99 %) | 0 diff (100 %id) |
AI027177 | parathyroid gland, parathyroid tumor | .a | 4722 to 5141 | 427 to 14 | | AAA | | 414/416 (99 %) | 9 diff (97.9 %id) |
R48788 | breast | .a | 4724 to 5141 | 420 to 1 | | fully sequenced, | | 420/420 (100 %) | 14 diff (96.7 %id) |
AW008073 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .a | 4725 to 5141 | 430 to 14 | | AAA | | 417/417 (100 %) | 1 diff (99.8 %id) |
AW151927 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .a | 4725 to 5141 | 417 to 1 | | | | 417/417 (100 %) | 2 diff (99.6 %id) |
AW190520 | adenocarcinoma, Pancreas | .a | 4725 to 5141 | 432 to 17 | | AAA | | 416/417 (99 %) | 0 diff (100 %id) |
AI817218 | lymph node, lymphoma, follicular mixed small and largecell | .a | 4727 to 5147 | 423 to 3 | | tiling clone, | | 421/423 (99 %) | 0 diff (100 %id) |
BF939209 | Prostate | .a | 4727 to 5146 | 433 to 13 | | AAA | | 421/421 (100 %) | 3 diff (99.3 %id) |
BQ718561 | sympathetic trunk | .a | 4727 to 5141 | 1 to 415 | | AAA | | 415/415 (100 %) | 0 diff (100 %id) |
AW131240 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .a | 4730 to 5141 | 412 to 1 | | | | 412/412 (100 %) | 0 diff (100 %id) |
AA463979 | ovarian tumor, ovary | .a | 4733 to 5143 | 411 to 1 | | fully sequenced, | | 411/411 (100 %) | 9 diff (97.9 %id) |
BQ002238 | Chondrosarcoma, Left Pelvis | .a | 4733 to 5146 | 433 to 19 | | AAA | | 415/415 (100 %) | 1 diff (99.8 %id) |
BG394134 | eye, retinoblastoma | .a | 4734 to 5146 | 1 to 414 | | AAA | | 414/414 (100 %) | 1 diff (99.8 %id) |
BG910299 | anaplastic oligodendroglioma with 1p/19qloss, brain | .a | 4734 to 5141 | 1 to 408 | | AAA | | 408/408 (100 %) | 1 diff (99.8 %id) |
R40610 | whole brain | .a | 4753 to 5142 | 406 to 9 | | | | 398/436 (91 %) | 0 diff (100 %id) |
H45699 | breast | .a | 4761 to 5122 | 365 to 1 | | fully sequenced, | | 365/365 (100 %) | 5 diff (98.7 %id) |
BP395697 | pancreatic islet | .a | 4762 to 5114 | 1 to 355 | | | Submitted on the opposite strand | 355/356 (99 %) | 3 diff (99.2 %id) |
AI360512 | lymph node, lymphoma, follicular mixed small and largecell | .a | 4762 to 5142 | 382 to 2 | | | | 381/382 (99 %) | 0 diff (100 %id) |
N26169 | melanocyte | .a | 4775 to 5141 | 371 to 1 | | | | 371/373 (99 %) | 8 diff (97.9 %id) |
H43345 | breast | .a | 4776 to 4897 | 1 to 121 | | | | 121/124 (97 %) | 2 diff (98.4 %id) |
AI688040 | colon | .a | 4776 to 5142 | 369 to 3 | | | | 367/369 (99 %) | 0 diff (100 %id) |
AW102704 | pooled | .a | 4781 to 5140 | 356 to 1 | | | | 356/409 (87 %) | 15 diff (96.4 %id) |
AA744027 | Prostate, stroma | .a | 4784 to 4944 | 1 to 164 | | | | 164/196 (83 %) | 9 diff (95.5 %id) |
AI073767 | parathyroid gland, parathyroid tumor | .a | 4785 to 5142 | 363 to 6 | | | | 358/363 (98 %) | 0 diff (100 %id) |
AI356720 | brain, glioblastoma (pooled) | .a | 4785 to 5147 | 365 to 3 | | | | 363/365 (99 %) | 0 diff (100 %id) |
AW339049 | adenocarcinoma, Pancreas | .a | 4785 to 5141 | 369 to 13 | | AAA | | 357/357 (100 %) | 2 diff (99.5 %id) |
AW576474 | lymph | .a | 4796 to 5146 | 368 to 18 | | AAA | | 351/351 (100 %) | 0 diff (100 %id) |
BM982110 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 4798 to 5146 | 367 to 19 | | AAA | | 349/349 (100 %) | 0 diff (100 %id) |
CK000949 | mixed | .a | 4802 to 5141 | 8 to 347 | | AAA | | 340/347 (97 %) | 6 diff (98.3 %id) |
AA470624 | colon | .a | 4806 to 5141 | 344 to 11 | | AAA | | 334/334 (100 %) | 4 diff (98.9 %id) |
AA351869 | brain | .a | 4810 to 5146 | 336 to 1 | | | | 336/336 (100 %) | 2 diff (99.5 %id) |
AI051880 | | .a | 4813 to 5141 | 327 to 1 | | | | 327/327 (100 %) | 8 diff (97.6 %id) |
AA043131 | uterus | .a | 4818 to 5144 | 340 to 1 | | fully sequenced, | | 340/340 (100 %) | 6 diff (98.3 %id) |
AI587039 | adenocarcinoma, Pancreas | .a | 4818 to 5141 | 364 to 42 | | AAA | | 323/324 (99 %) | 0 diff (100 %id) |
AI886337 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 4824 to 5141 | 317 to 1 | | | | 317/317 (100 %) | 4 diff (98.8 %id) |
AI251816 | brain, tumor, 5 pooled (see description) | .a | 4836 to 5147 | 311 to 1 | | | | 311/311 (100 %) | 1 diff (99.7 %id) |
AW078590 | 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney | .a | 4836 to 5142 | 312 to 4 | | | | 309/312 (99 %) | 0 diff (100 %id) |
BE041722 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 4865 to 5147 | 285 to 7 | | | | 279/322 (86 %) | 0 diff (100 %id) |
AA164609 | | .a | 4867 to 4962 | 1 to 95 | | | | 95/95 (100 %) | 4 diff (95.8 %id) |
AA351411 | brain | .a | 4879 to 5141 | 262 to 1 | | | | 262/273 (95 %) | 1 diff (99.7 %id) |
AA384737 | thyroid gland | .a | 4893 to 5141 | 1 to 249 | | | | 249/249 (100 %) | 0 diff (100 %id) |
AI702299 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 4897 to 5141 | 256 to 13 | | AAA | | 244/244 (100 %) | 1 diff (99.6 %id) |
BQ024086 | placenta | .a | 4903 to 5141 | 257 to 19 | | AAA | | 239/239 (100 %) | 1 diff (99.6 %id) |
BU738760 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 4903 to 5141 | 257 to 19 | | AAA | | 239/239 (100 %) | 0 diff (100 %id) |
CA433596 | mixed | .a | 4905 to 5141 | 255 to 19 | | AAA | | 237/237 (100 %) | 0 diff (100 %id) |
H43307 | breast | .a | 4915 to 5128 | 214 to 1 | | | | 214/219 (97 %) | 2 diff (99.1 %id) |
AI383682 | | .a | 4932 to 5141 | 209 to 1 | | | | 209/209 (100 %) | 1 diff (99.6 %id) |
BQ030269 | lung, Metastatic Chondrosarcoma | .a | 4936 to 5146 | 230 to 20 | | AAA | | 211/211 (100 %) | 0 diff (100 %id) |
AW960465 | | .a | 4937 to 5140 | 204 to 1 | | | Submitted on the opposite strand | 204/294 (69 %) | 5 diff (98.3 %id) |
AA328099 | | .a | 4947 to 5141 | 1 to 195 | | | | 195/195 (100 %) | 0 diff (100 %id) |
AW576589 | lymph | .a | 5029 to 5141 | 132 to 20 | | | | 113/132 (85 %) | 0 diff (100 %id) |
AI687845 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .a | 5045 to 5142 | 101 to 4 | | | | 98/101 (97 %) | 0 diff (100 %id) |
AB209473 | brain | .b | 1 to 5760 | 2 to 5761 | Q1047E | tiling clone, | | 5761/5761 (100 %) | 1 diff (100.0 %id) |
DA064934 | cerebellum | .b | 1 to 560 | 2 to 560 | | capped | | 559/559 (100 %) | 1 diff (99.9 %id) |
N46406.
matches multiple genes | melanocyte | .b | 7 to 448 | 1 to 445 | | | also hits gene PARD3 | 445/447 (99 %) | 8 diff (98.3 %id) |
BI915460 | brain | .b | 19 to 699 | 1 to 705 | | | | 705/971 (72 %) | 63 diff (93.6 %id) |
TI_57239347 | | .b | 21 to 699 | 74 to 776 | | | | 703/1042 (67 %) | 64 diff (93.9 %id) |
BI039226 | nervous_tumor | .b | 336 to 681 | 346 to 1 | | | | 346/346 (100 %) | 2 diff (99.5 %id) |
TI_154161535 | | .b | 724 to 1237 | 93 to 610 | | | | 518/612 (84 %) | 68 diff (88.9 %id) |
AW500269 | lymph | .b | 1611 to 2077 | 8 to 474 | | | | 467/474 (98 %) | 6 diff (98.8 %id) |
TI_154154395 | | .b | 1611 to 2262 | 80 to 730 | | | | 651/652 (99 %) | 4 diff (99.4 %id) |
TI_2194697047 | | .b | 1730 to 2949 | 19 to 1218 | | | | 1200/1271 (94 %) | 31 diff (97.6 %id) |
BF912782 | uterus_tumor | .b | 2066 to 2268 | 1 to 203 | | | | 203/232 (87 %) | 12 diff (94.9 %id) |
BF912807 | uterus_tumor | .b | 2066 to 2547 | 1 to 482 | | | | 482/482 (100 %) | 2 diff (99.6 %id) |
BF913943 | uterus_tumor | .b | 2066 to 2513 | 1 to 448 | | | | 448/448 (100 %) | 15 diff (96.7 %id) |
AI903931 | breast | .b | 2099 to 2287 | 1 to 189 | | | | 189/193 (97 %) | 1 diff (99.5 %id) |
BX451436 | placenta | .b | 2099 to 2945 | 1 to 853 | | | | 853/853 (100 %) | 10 diff (98.9 %id) |
BU845710 | ovary, teratocarcinoma, cell line | .b | 2257 to 2976 | 1 to 722 | | | | 722/945 (76 %) | 29 diff (97.0 %id) |
TI_2194697073 | | .b | 2278 to 3462 | 1 to 1172 | | | | 1172/1280 (91 %) | 25 diff (98.1 %id) |
BG748310 | eye, normal pigmented retinal epithelium | .b | 2363 to 2955 | 1 to 613 | | | | 613/685 (89 %) | 34 diff (95.1 %id) |
AL121357 | melanoma (MeWo cell line) | .b | 2563 to 3091 | 1 to 529 | | | | 529/529 (100 %) | 2 diff (99.7 %id) |
BQ218710 | leiomyosarcoma, uterus | .b | 2631 to 3492 | 1 to 877 | | | | 877/998 (87 %) | 21 diff (97.9 %id) |
TI_2194697074 | | .b | 2637 to 3808 | 16 to 1178 | | | | 1163/1288 (90 %) | 13 diff (99.0 %id) |
BM458564 | lymph, lymphoma, cell line | .b | 2664 to 3237 | 1 to 581 | | | | 581/1114 (52 %) | 12 diff (99.0 %id) |
AA335702 | epididymis | .b | 2688 to 2843 | 1 to 157 | | | | 157/306 (51 %) | 0 diff (100 %id) |
BE871935 | adenocarcinoma, colon | .b | 2792 to 3533 | 14 to 735 | | | | 722/871 (82 %) | 33 diff (96.3 %id) |
TI_1968233415 | | .b | 2842 to 3893 | 37 to 1090 | | | | 1054/1305 (80 %) | 32 diff (97.6 %id) |
BX335794 | Placenta Cot 25-normalized | .b | 2844 to 3641 | 1 to 801 | | | | 801/801 (100 %) | 18 diff (97.8 %id) |
BI910758 | leukocyte | .b | 2846 to 3548 | 9 to 714 | | | | 705/714 (98 %) | 7 diff (99.1 %id) |
TI_57237509 | | .b | 2846 to 3548 | 38 to 743 | | | | 705/743 (94 %) | 7 diff (99.1 %id) |
BF877408 | lung_tumor | .b | 2860 to 3215 | 1 to 355 | | | | 355/355 (100 %) | 1 diff (99.8 %id) |
BI001239 | head_normal | .b | 2914 to 3393 | 494 to 16 | | | | 479/496 (96 %) | 9 diff (98.2 %id) |
BU855997 | ovary, teratocarcinoma, cell line | .b | 2942 to 3805 | 26 to 895 | | | | 870/943 (92 %) | 17 diff (98.2 %id) |
TI_2194696696 | | .b | 3013 to 4017 | 1026 to 21 | | | | 1006/1302 (77 %) | 2 diff (99.9 %id) |
CD626853 | | .b | 3039 to 3761 | 1 to 721 | | | | 721/721 (100 %) | 3 diff (99.6 %id) |
AA447269 | Prostate | .b | 3061 to 3583 | 14 to 535 | | | | 522/535 (97 %) | 16 diff (97.1 %id) |
BQ343499 | nervous_tumor | .b | 3152 to 3433 | 18 to 299 | | | | 284/311 (91 %) | 8 diff (97.5 %id) |
BU145918 | dorsal root ganglia | .b | 3190 to 4016 | 1 to 831 | | | | 831/946 (87 %) | 11 diff (98.9 %id) |
TI_1968232539 | | .b | 3203 to 4358 | 1163 to 17 | | | | 1147/1208 (94 %) | 22 diff (98.2 %id) |
BC021244 | Pancreas, epithelioid carcinoma | .b | 3224 to 5760 | 1 to 2537 | | tiling clone, available from MGC, AAA | | 2537/2537 (100 %) | 1 diff (100.0 %id) |
BF568143 | epithelioid carcinoma cell line, Pancreas | .b | 3224 to 3993 | 1 to 761 | | available from MGC, | | 761/766 (99 %) | 20 diff (97.4 %id) |
BQ379902 | uterus_tumor | .b | 3227 to 3662 | 1 to 436 | | | | 436/436 (100 %) | 8 diff (98.2 %id) |
TI_2194696660 | | .b | 3238 to 4358 | 1121 to 17 | | | | 1105/1260 (87 %) | 22 diff (98.3 %id) |
CT004775 | T-Lymphocytes | .b | 3243 to 3874 | 1 to 632 | | | | 632/632 (100 %) | 0 diff (100 %id) |
TI_2194697068 | | .b | 3245 to 4429 | 1185 to 8 | | | | 1178/1291 (91 %) | 13 diff (99.0 %id) |
TI_2194697075 | | .b | 3254 to 4465 | 8 to 1204 | | | | 1199/1298 (92 %) | 28 diff (97.9 %id) |
BX956428 | | .b | 3271 to 3700 | 1 to 430 | | | | 430/430 (100 %) | 0 diff (100 %id) |
CB268224 | adipose | .b | 3289 to 3791 | 11 to 513 | | | | 503/513 (98 %) | 12 diff (97.7 %id) |
BQ708438 | Spleen | .b | 3299 to 4015 | 1 to 725 | | | | 725/945 (76 %) | 23 diff (97.6 %id) |
BU156261 | melanotic melanoma, skin | .b | 3315 to 3771 | 1 to 464 | | | | 464/652 (71 %) | 14 diff (97.9 %id) |
BU931179 | ovary, teratocarcinoma, cell line | .b | 3326 to 4208 | 1 to 892 | | | | 890/892 (99 %) | 15 diff (98.4 %id) |
BY800172 | eye | .b | 3328 to 3913 | 11 to 596 | | | | 586/596 (98 %) | 6 diff (99.0 %id) |
BI061792 | uterus_tumor | .b | 3376 to 3640 | 274 to 14 | | | | 261/275 (94 %) | 1 diff (99.7 %id) |
TI_2194696698 | | .b | 3391 to 4357 | 995 to 24 | | | | 972/1133 (85 %) | 20 diff (98.3 %id) |
BF316081 | brain, neuroblastoma | .b | 3391 to 4076 | 10 to 694 | | | | 686/695 (98 %) | 16 diff (97.7 %id) |
CN350993 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 3398 to 3757 | 1 to 361 | | | | 361/361 (100 %) | 1 diff (99.8 %id) |
BE314106 | brain, neuroblastoma | .b | 3402 to 3800 | 1 to 402 | | available from MGC, | | 402/403 (99 %) | 12 diff (97.1 %id) |
TI_154159539 | | .b | 3486 to 4067 | 174 to 755 | | | | 582/665 (87 %) | 17 diff (97.5 %id) |
CB216802 | normal endometrium, mid-secretory phase,cycle day 23, uterus | .b | 3544 to 4088 | 1 to 545 | | | | 545/546 (99 %) | 3 diff (99.5 %id) |
BG281212 | melanotic melanoma, skin | .b | 3549 to 4232 | 1 to 685 | | | | 685/685 (100 %) | 10 diff (98.6 %id) |
BG334704 | melanotic melanoma, skin | .b | 3549 to 4266 | 1 to 716 | | | | 716/721 (99 %) | 6 diff (99.2 %id) |
BE274316 | melanotic melanoma, skin | .b | 3569 to 4355 | 1 to 784 | | | | 784/865 (90 %) | 13 diff (98.5 %id) |
BE386427 | melanotic melanoma, skin | .b | 3569 to 4252 | 1 to 680 | | | | 680/713 (95 %) | 13 diff (98.2 %id) |
BE384384 | melanotic melanoma, skin | .b | 3571 to 4272 | 1 to 704 | | | | 704/755 (93 %) | 24 diff (96.9 %id) |
BI004933 | head_normal | .b | 3590 to 4031 | 11 to 457 | | | | 447/459 (97 %) | 21 diff (95.5 %id) |
TI_2194697071 | | .b | 3616 to 4743 | 14 to 1129 | | | | 1116/1283 (86 %) | 16 diff (98.8 %id) |
AW499929 | lymph | .b | 3710 to 4280 | 1 to 571 | | | | 571/571 (100 %) | 3 diff (99.5 %id) |
TI_154153992 | | .b | 3717 to 4345 | 80 to 708 | | | | 629/631 (99 %) | 2 diff (99.7 %id) |
TI_2194696663 | | .b | 3759 to 4929 | 1168 to 9 | | | | 1160/1263 (91 %) | 23 diff (98.2 %id) |
BG750808 | eye, normal pigmented retinal epithelium | .b | 3775 to 4399 | 1 to 626 | | | | 626/626 (100 %) | 5 diff (99.3 %id) |
BF834408 | head_neck | .b | 3778 to 4165 | 1 to 390 | | | | 392/392 (100 %) | 11 diff (97.2 %id) |
BG765449 | melanotic melanoma, high MDR (cell line), skin | .b | 3787 to 4004 | 1 to 218 | | | | 218/218 (100 %) | 1 diff (99.6 %id) |
BM050648 | eye, normal pigmented retinal epithelium | .b | 3841 to 4663 | 1 to 840 | | | | 840/940 (89 %) | 40 diff (95.8 %id) |
BQ364056 | stomach | .b | 3846 to 4158 | 6 to 317 | | | | 312/317 (98 %) | 9 diff (97.2 %id) |
BI019911 | marrow | .b | 3969 to 4380 | 412 to 1 | | | | 412/430 (95 %) | 0 diff (100 %id) |
BX391766 | Placenta Cot 25-normalized | .b | 4015 to 4925 | 913 to 5 | | | | 909/917 (99 %) | 13 diff (98.6 %id) |
BG104546 | adrenal cortex carcinoma, cell line, adrenal gland | .b | 4024 to 4796 | 1 to 764 | | | | 764/977 (78 %) | 21 diff (97.9 %id) |
BQ056545 | lymph, lymphoma, cell line | .b | 4071 to 4886 | 1 to 855 | | | | 843/1058 (79 %) | 29 diff (97.3 %id) |
BQ058949 | lymph, lymphoma, cell line | .b | 4071 to 4803 | 1 to 735 | | | | 735/1098 (66 %) | 5 diff (99.6 %id) |
BG292402 | bladder, transitional cell papilloma, cell line | .b | 4073 to 4805 | 1 to 728 | | | | 728/966 (75 %) | 26 diff (97.4 %id) |
AA351412 | brain | .b | 4081 to 4445 | 1 to 365 | | | | 365/365 (100 %) | 2 diff (99.5 %id) |
BE279687 | choriocarcinoma, placenta | .b | 4085 to 4684 | 1 to 600 | | | | 600/600 (100 %) | 0 diff (100 %id) |
AW801689 | uterus | .b | 4108 to 4542 | 435 to 2 | | | | 434/435 (99 %) | 1 diff (99.8 %id) |
BE774226 | uterus | .b | 4114 to 4311 | 200 to 1 | | | | 200/222 (90 %) | 15 diff (93.3 %id) |
BG831886 | epithelioid carcinoma cell line, Pancreas | .b | 4120 to 4825 | 1 to 702 | | | | 702/702 (100 %) | 6 diff (99.2 %id) |
AW801630 | uterus | .b | 4128 to 4542 | 416 to 2 | | | | 415/416 (99 %) | 0 diff (100 %id) |
CX787380 | human embryonic stem cells | .b | 4133 to 4795 | 1 to 663 | | | | 663/663 (100 %) | 1 diff (99.9 %id) |
BI771822 | pooled lung and spleen | .b | 4153 to 4767 | 1 to 620 | | | | 620/621 (99 %) | 7 diff (98.9 %id) |
TI_57179558 | | .b | 4153 to 4767 | 34 to 653 | | | | 620/654 (94 %) | 13 diff (98.1 %id) |
BF846442 | lung_normal | .b | 4163 to 4545 | 32 to 413 | | | | 382/419 (91 %) | 8 diff (98.1 %id) |
TI_2194697084 | | .b | 4165 to 5241 | 15 to 1086 | | | | 1072/1281 (83 %) | 12 diff (99.1 %id) |
TI_2194695083 | | .b | 4169 to 5247 | 1178 to 116 | | | | 1063/1290 (82 %) | 42 diff (96.8 %id) |
BE791787 | lung, small cell carcinoma | .b | 4180 to 4805 | 1 to 640 | | | | 640/1027 (62 %) | 21 diff (98.0 %id) |
BG116687 | duodenal adenocarcinoma, cell line, small intestine | .b | 4187 to 4888 | 1 to 702 | | | | 702/1101 (63 %) | 15 diff (98.7 %id) |
TI_1968230481 | | .b | 4221 to 5256 | 1145 to 109 | | | | 1037/1301 (79 %) | 14 diff (99.0 %id) |
TI_57217647 | | .b | 4226 to 5001 | 62 to 838 | | | | 777/855 (90 %) | 21 diff (97.6 %id) |
BI752962 | brain | .b | 4233 to 5001 | 1 to 770 | | | | 770/787 (97 %) | 15 diff (98.1 %id) |
AW801453 | uterus | .b | 4253 to 4542 | 291 to 2 | | | | 290/291 (99 %) | 0 diff (100 %id) |
TI_2194699508 | | .b | 4270 to 5247 | 1084 to 112 | | | | 973/1280 (76 %) | 7 diff (99.5 %id) |
BX431031 | brain, fetal brain | .b | 4271 to 5137 | 1 to 863 | | | | 863/863 (100 %) | 15 diff (98.3 %id) |
BX431030 | brain, fetal brain | .b | 4272 to 5072 | 1 to 806 | | | | 806/848 (95 %) | 9 diff (99.0 %id) |
CK819022 | Islets of Langerhans, Pancreas | .b | 4277 to 4856 | 1 to 580 | | | | 580/580 (100 %) | 0 diff (100 %id) |
BM126430 | Islets of Langerhans, Pancreas | .b | 4293 to 4859 | 1 to 567 | | | | 567/567 (100 %) | 0 diff (100 %id) |
D78704 | placenta | .b | 4305 to 4527 | 1 to 223 | | | | 223/223 (100 %) | 3 diff (98.7 %id) |
TI_44458979 | | .b | 4322 to 5153 | 106 to 936 | | | | 831/965 (86 %) | 11 diff (98.9 %id) |
BI518631 | leukocyte | .b | 4325 to 5182 | 1 to 857 | | | | 857/857 (100 %) | 5 diff (99.5 %id) |
BF757346 | colon | .b | 4353 to 4503 | 1 to 152 | | | | 152/155 (98 %) | 9 diff (94.2 %id) |
AA295815 | thymus | .b | 4356 to 4648 | 1 to 293 | | | | 293/293 (100 %) | 1 diff (99.7 %id) |
BI518964 | leukocyte | .b | 4360 to 5287 | 1 to 927 | | | | 927/940 (98 %) | 24 diff (97.5 %id) |
TI_44459547 | | .b | 4360 to 5287 | 94 to 1020 | | | | 927/1033 (89 %) | 30 diff (97.1 %id) |
BI050033 | placenta_normal | .b | 4392 to 4647 | 1 to 255 | | | | 255/256 (99 %) | 5 diff (98.1 %id) |
BF909988 | uterus_tumor | .b | 4426 to 4586 | 160 to 1 | | | Submitted on the opposite strand | 160/282 (56 %) | 5 diff (98.3 %id) |
BQ376907 | uterus | .b | 4448 to 4716 | 11 to 279 | | | | 269/286 (94 %) | 7 diff (97.6 %id) |
BE886290 | leiomyosarcoma, uterus | .b | 4486 to 5086 | 1 to 606 | | | | 603/606 (99 %) | 16 diff (97.4 %id) |
AA376996 | small intestine | .b | 4554 to 4877 | 1 to 325 | | | | 325/325 (100 %) | 1 diff (99.7 %id) |
AA299535 | uterus | .b | 4579 to 4789 | 1 to 211 | | | | 211/211 (100 %) | 1 diff (99.6 %id) |
AW957026 | | .b | 4580 to 5002 | 1 to 423 | | | | 423/513 (82 %) | 5 diff (99.1 %id) |
CN350994 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 4608 to 5252 | 1 to 645 | | | | 645/645 (100 %) | 0 diff (100 %id) |
AW840772 | colon_normal | .b | 4616 to 4714 | 8 to 106 | | | | 99/106 (93 %) | 6 diff (94.4 %id) |
BX360641 | Placenta Cot 25-normalized | .b | 4656 to 5704 | 1069 to 34 | | | | 1036/1069 (96 %) | 14 diff (98.7 %id) |
BQ052804 | blood, natural killer cells, cell line | .b | 4669 to 5453 | 1 to 786 | | | | 786/1052 (74 %) | 20 diff (98.1 %id) |
BQ054366 | blood, natural killer cells, cell line | .b | 4669 to 5496 | 1 to 859 | | | | 859/1085 (79 %) | 35 diff (96.8 %id) |
BM142004 | Islets of Langerhans, Pancreas | .b | 4721 to 5241 | 1 to 521 | | | | 521/521 (100 %) | 0 diff (100 %id) |
TI_2194697085 | | .b | 4725 to 5247 | 16 to 536 | | | | 521/1291 (40 %) | 7 diff (99.5 %id) |
BM788913 | stomach | .b | 4768 to 5436 | 1 to 669 | | | | 669/669 (100 %) | 0 diff (100 %id) |
BG910790 | anaplastic oligodendroglioma with 1p/19qloss, brain | .b | 4775 to 5586 | 1 to 815 | | | | 815/815 (100 %) | 17 diff (98.0 %id) |
BG910630 | anaplastic oligodendroglioma with 1p/19qloss, brain | .b | 4775 to 5494 | 1 to 726 | | | | 726/727 (99 %) | 31 diff (95.8 %id) |
BQ649115 | hepatocellular carcinoma, cell line, Liver | .b | 4780 to 5636 | 18 to 878 | | | | 861/942 (91 %) | 22 diff (97.7 %id) |
BQ643666 | hepatocellular carcinoma, cell line, Liver | .b | 4782 to 5424 | 26 to 682 | | | | 660/973 (67 %) | 32 diff (96.8 %id) |
BE746390 | adenocarcinoma cell line, ovary | .b | 4786 to 5214 | 1 to 435 | | | | 435/435 (100 %) | 5 diff (98.9 %id) |
H59671 | liver and spleen | .b | 4807 to 5153 | 1 to 346 | | | | 346/348 (99 %) | 2 diff (99.5 %id) |
BE819007 | breast_normal | .b | 4817 to 5139 | 1 to 323 | | | | 323/323 (100 %) | 0 diff (100 %id) |
R35566 | placenta | .b | 4833 to 5075 | 1 to 242 | | | | 242/246 (98 %) | 3 diff (98.8 %id) |
BF029889 | hypernephroma, Kidney | .b | 4857 to 4983 | 1 to 127 | | | | 127/127 (100 %) | 1 diff (99.3 %id) |
R34239 | placenta | .b | 5509 to 5745 | 235 to 1 | | | | 235/236 (99 %) | 2 diff (99.2 %id) |
NM_015242.4 | | .c | 1 to 4946 | 2 to 4947 | exact | RefSeq, AAA | | 4947/4947 (100 %) | 0 diff (100 %id) |
AB018325 | brain | .c | 23 to 4941 | 1 to 4919 | exact | tiling clone, available from KIAA, | | 4919/4919 (100 %) | 2 diff (100.0 %id) |
BC144562 | Brain, cerebellum, PCR rescued clones | .d | 1 to 4066 | 1 to 4066 | S834R | tiling clone, | | 4066/4066 (100 %) | 2 diff (100.0 %id) |
NM_001135190.1 | | .e | 1 to 4730 | 2 to 4731 | | RefSeq, AAA | | 4731/4731 (100 %) | 0 diff (100 %id) |
DA186424 | amygdala | .e | 1 to 554 | 2 to 555 | | tiling clone, capped | | 554/554 (100 %) | 0 diff (100 %id) |
AL598152 | | .e | 17 to 336 | 1 to 320 | | | | 320/320 (100 %) | 5 diff (98.5 %id) |
BQ921498 | leiomyosarcoma, uterus | .e | 29 to 860 | 1 to 839 | | | | 839/848 (98 %) | 16 diff (98.2 %id) |
BP288441 | lung | .e | 35 to 619 | 1 to 583 | | | | 583/583 (100 %) | 7 diff (98.8 %id) |
BP219870 | caudate nucleus | .e | 37 to 628 | 1 to 592 | | | | 592/592 (100 %) | 14 diff (97.7 %id) |
BP350588 | | .e | 37 to 618 | 1 to 582 | | | | 582/582 (100 %) | 4 diff (99.4 %id) |
DA979328 | synovial membrane tissue from rheumatioidarthritis | .e | 38 to 606 | 2 to 570 | | capped | | 569/569 (100 %) | 3 diff (99.5 %id) |
BM194453 | leukopheresis | .e | 88 to 478 | 1 to 391 | | | | 391/391 (100 %) | 2 diff (99.5 %id) |
BP314487 | mammary gland | .e | 89 to 670 | 1 to 582 | | | | 582/582 (100 %) | 0 diff (100 %id) |
DA990917 | synovial membrane tissue from rheumatioidarthritis | .e | 139 to 672 | 2 to 535 | | capped | | 534/534 (100 %) | 3 diff (99.5 %id) |
AI494514 | anaplastic oligodendroglioma, brain | .e | 280 to 556 | 277 to 2 | | | | 276/277 (99 %) | 0 diff (100 %id) |
AI934649 | anaplastic oligodendroglioma, brain | .e | 280 to 551 | 274 to 3 | | | | 272/274 (99 %) | 0 diff (100 %id) |
AI564905 | anaplastic oligodendroglioma, brain | .e | 312 to 556 | 244 to 2 | | | | 243/244 (99 %) | 8 diff (96.8 %id) |
BC140792 | Brain, cerebellum, PCR rescued clones | .e | 330 to 4212 | 1 to 3883 | | tiling clone, | | 3883/3883 (100 %) | 1 diff (100.0 %id) |
TI_2194695075 | | .e | 330 to 1412 | 90 to 1185 | | | | 1096/1275 (85 %) | 44 diff (96.6 %id) |
TI_2194699130 | | .e | 330 to 1350 | 80 to 1092 | | | | 1013/1271 (79 %) | 19 diff (98.6 %id) |
CN350995 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .e | 337 to 862 | 1 to 527 | | | | 527/527 (100 %) | 1 diff (99.9 %id) |
BI771300 | pooled lung and spleen | .e | 1730 to 2524 | 1 to 794 | | | | 794/795 (99 %) | 6 diff (99.3 %id) |
TI_57179138 | | .e | 1730 to 2524 | 27 to 820 | | | | 794/821 (96 %) | 12 diff (98.6 %id) |
BC008315 | Brain, neuroblastoma | .e | 2347 to 4730 | 1 to 2384 | | tiling clone, available from MGC, AAA | | 2384/2384 (100 %) | 0 diff (100 %id) |
AK160383 | Spleen | .f | 1 to 5612 | 1 to 5614 | Q285E A304P F590L G591W L592A ... | tiling clone, available from FLJ, | | 5614/5614 (100 %) | 12 diff (99.8 %id) |
BX459126 | placenta | .f | 822 to 1711 | 1 to 889 | | | | 889/889 (100 %) | 0 diff (100 %id) |
BX460550 | brain, fetal brain | .f | 3326 to 4204 | 1 to 877 | | | | 877/877 (100 %) | 9 diff (99.0 %id) |
AW794032 | uterus | .f | 3529 to 3828 | 6 to 303 | | | | 298/307 (97 %) | 6 diff (98.1 %id) |
CV346665 | uterus | .f | 3542 to 3842 | 303 to 2 | | | Submitted on the opposite strand | 302/303 (99 %) | 0 diff (100 %id) |
AW369782 | breast | .f | 3781 to 4082 | 34 to 333 | | | | 300/333 (90 %) | 6 diff (98.2 %id) |
BF770853 | epid_tumor | .f | 3793 to 4295 | 8 to 506 | | | | 499/506 (98 %) | 8 diff (98.5 %id) |
AL545633 | placenta, Placenta Cot 25-normalized | .g | 1 to 992 | 1 to 993 | | tiling clone, | | 993/1131 (87 %) | 11 diff (99.1 %id) |
BX360487 | Placenta Cot 25-normalized | .g | 9 to 968 | 1 to 949 | | tiling clone, | | 949/949 (100 %) | 19 diff (98.0 %id) |
AL571379 | placenta, Placenta Cot 25-normalized | .g | 1744 to 2914 | 1156 to 1 | | tiling clone, | | 1156/1156 (100 %) | 28 diff (97.6 %id) |
BX392915 | Placenta Cot 25-normalized | .g | 2487 to 2944 | 463 to 4 | | tiling clone, | | 460/470 (97 %) | 0 diff (100 %id) |
BC056401 | Brain, adult medulla | .h | 1 to 2757 | 1 to 2757 | I2M V638M | tiling clone, available from MGC, AAA | | 2757/2757 (100 %) | 2 diff (100.0 %id) |
BM554299 | brain, medulla | .h | 1 to 1005 | 1 to 1008 | | available from MGC, | | 1006/1015 (99 %) | 19 diff (98.2 %id) |
BF515837 | | .i | 1 to 523 | 523 to 1 | | tiling clone, | | 523/523 (100 %) | 0 diff (100 %id) |
AW449004 | | .i | 26 to 523 | 498 to 1 | | | | 498/501 (99 %) | 0 diff (100 %id) |
BF590967 | colon, colon tumor, RER+ | .i | 94 to 488 | 398 to 3 | | | | 396/398 (99 %) | 0 diff (100 %id) |
CF138996 | CNCAP(3)T-225 cell line, Prostate | .i | 494 to 868 | 8 to 382 | | | | 375/382 (98 %) | 8 diff (98.0 %id) |
TI_154169147 | | .i | 494 to 1001 | 80 to 587 | | | | 508/508 (100 %) | 7 diff (98.7 %id) |
DB494769 | hypothalamus | .i | 512 to 1003 | 1 to 492 | | tiling clone, | | 492/492 (100 %) | 2 diff (99.6 %id) |
BM924353 | pooled colon, kidney, stomach | .i | 523 to 1091 | 1 to 570 | | | | 570/941 (60 %) | 18 diff (98.1 %id) |
BQ927250 | carcinoma, cell line, Prostate | .i | 524 to 1408 | 1 to 896 | | | | 896/970 (92 %) | 28 diff (97.2 %id) |
BQ919172 | carcinoma, cell line, Prostate | .i | 524 to 1038 | 1 to 516 | | | | 516/1015 (50 %) | 15 diff (98.6 %id) |
BU502683 | carcinoma, cell line, Prostate | .i | 524 to 1022 | 1 to 499 | | | | 499/1413 (35 %) | 6 diff (99.6 %id) |
CA392767 | eye, RPE/choroid | .i | 531 to 1053 | 1 to 523 | | | | 523/523 (100 %) | 0 diff (100 %id) |
BQ072338 | pooled lung and spleen | .i | 531 to 1030 | 1 to 503 | | | | 503/1281 (39 %) | 33 diff (97.5 %id) |
BU599374 | mixed (pool of 40 RNAs) | .i | 531 to 885 | 1 to 360 | | | | 360/867 (41 %) | 21 diff (97.6 %id) |
BX397226 | Placenta Cot 25-normalized | .i | 532 to 1583 | 1 to 1037 | | | | 1037/1040 (99 %) | 24 diff (97.7 %id) |
BX402417 | Placenta Cot 25-normalized | .i | 532 to 1549 | 1 to 1004 | | | | 1006/1102 (91 %) | 18 diff (98.4 %id) |
BG170683 | hypernephroma, cell line, Kidney | .i | 532 to 840 | 1 to 310 | | | | 310/310 (100 %) | 1 diff (99.7 %id) |
BQ787139 | Pancreas, Purified pancreatic islet | .i | 538 to 990 | 1 to 453 | | | | 453/453 (100 %) | 6 diff (98.7 %id) |
CK431235 | eye, lacrimal gland | .i | 539 to 1162 | 1 to 624 | | | | 624/624 (100 %) | 0 diff (100 %id) |
CR599708 | placenta | .i | 540 to 1463 | 1 to 924 | | | | 924/924 (100 %) | 0 diff (100 %id) |
AL541272 | placenta | .i | 540 to 1463 | 1 to 920 | | fully sequenced, | | 920/920 (100 %) | 5 diff (99.5 %id) |
DR421611 | eye, Pterygium | .i | 543 to 1089 | 1 to 547 | | | | 547/550 (99 %) | 1 diff (99.9 %id) |
BG654833 | Pancreas, Purified pancreatic islet | .i | 545 to 1019 | 1 to 475 | | | | 475/475 (100 %) | 3 diff (99.4 %id) |
BG468468 | adenocarcinoma cell line, colon | .i | 571 to 1007 | 1 to 441 | | | | 441/1010 (43 %) | 6 diff (99.5 %id) |
BG821711 | adenocarcinoma cell line, colon | .i | 577 to 1353 | 1 to 775 | | | | 775/775 (100 %) | 8 diff (99.0 %id) |
CN368916 | embryonic stem cells, cell lines H1, H7, andH9 | .i | 631 to 1277 | 1 to 647 | | | | 647/647 (100 %) | 3 diff (99.6 %id) |
CA488341 | | .i | 633 to 1166 | 1 to 540 | | | | 540/840 (64 %) | 11 diff (98.7 %id) |
BG752210 | eye, normal pigmented retinal epithelium | .i | 634 to 1458 | 1 to 831 | | | | 831/871 (95 %) | 21 diff (97.6 %id) |
BG751000 | eye, normal pigmented retinal epithelium | .i | 635 to 1391 | 1 to 760 | | | | 760/761 (99 %) | 6 diff (99.3 %id) |
CD671970 | eye, Iris | .i | 637 to 1285 | 1 to 649 | | | | 649/649 (100 %) | 0 diff (100 %id) |
BM925689 | brain | .i | 644 to 1547 | 1 to 914 | | | | 914/1043 (87 %) | 17 diff (98.4 %id) |
BX462965 | fetal liver, Liver | .i | 646 to 1629 | 1 to 961 | | | | 961/1063 (90 %) | 29 diff (97.3 %id) |
BC000020 | Placenta, choriocarcinoma | .i | 647 to 1873 | 1116 to 2343 | | tiling clone, AAA | | 1228/2343 (52 %) | 7 diff (99.8 %id) |
CA454202 | | .i | 651 to 1518 | 1 to 881 | | | | 881/881 (100 %) | 13 diff (98.6 %id) |
CA489692 | | .i | 662 to 1289 | 1 to 628 | | | | 628/891 (70 %) | 2 diff (99.8 %id) |
BI523593 | pooled lung and spleen | .i | 690 to 1128 | 1 to 437 | | fully sequenced, | | 437/437 (100 %) | 3 diff (99.4 %id) |
TI_44159069 | | .i | 690 to 1128 | 38 to 474 | | fully sequenced, | | 437/474 (92 %) | 12 diff (97.5 %id) |
CA488975 | | .i | 693 to 1558 | 1 to 872 | | | | 872/907 (96 %) | 15 diff (98.4 %id) |
CK822460 | Pancreas, Purified pancreatic islet | .i | 699 to 1227 | 6 to 534 | | | Submitted on the opposite strand | 529/534 (99 %) | 6 diff (98.9 %id) |
BI524441 | pooled lung and spleen | .i | 1098 to 1756 | 659 to 1 | | tiling clone, fully sequenced, | | 659/659 (100 %) | 1 diff (99.9 %id) |
TI_44159070 | | .i | 1098 to 1766 | 707 to 39 | | fully sequenced, | | 669/707 (94 %) | 0 diff (100 %id) |
AL568827 | placenta | .i | 1230 to 1463 | 234 to 1 | | fully sequenced, | | 234/234 (100 %) | 2 diff (99.2 %id) |
CD671969 | eye, Iris | .i | 1476 to 1753 | 279 to 2 | | | | 278/279 (99 %) | 0 diff (100 %id) |
BU542128 | carcinoma, cell line, Prostate | .j | 1 to 540 | 1 to 544 | | tiling clone, | | 544/1104 (49 %) | 16 diff (98.6 %id) |
BX337923 | Placenta Cot 25-normalized | .j | 8 to 1090 | 1 to 1075 | | tiling clone, | | 1075/1119 (96 %) | 13 diff (98.9 %id) |
DA831752 | placenta | .j | 207 to 934 | 2 to 734 | | capped | | 733/737 (99 %) | 9 diff (98.8 %id) |
CA773927 | Pancreas, Purified pancreatic islet | .k | 1 to 460 | 1 to 460 | | tiling clone, | | 460/460 (100 %) | 5 diff (99.0 %id) |
BU069199 | Pancreas, Purified pancreatic islet | .k | 463 to 1046 | 585 to 1 | | tiling clone, | | 585/585 (100 %) | 1 diff (99.9 %id) |
BX360642 | Placenta Cot 25-normalized | .l | 1 to 994 | 1 to 985 | | tiling clone, | | 985/985 (100 %) | 15 diff (98.5 %id) |
BX417005 | placenta | .l | 59 to 989 | 1 to 928 | | tiling clone, | | 928/928 (100 %) | 4 diff (99.6 %id) |
BF683863 | leiomyosarcoma cell line, uterus | .m | 1 to 815 | 1 to 804 | | tiling clone, | | 804/932 (86 %) | 40 diff (95.8 %id) |
BC007919 | Uterus, leiomyosarcoma | .m | 2 to 1507 | 1 to 1506 | exact | tiling clone, available from MGC, AAA | | 1506/1506 (100 %) | 0 diff (100 %id) |
BC014033 | Uterus, leiomyosarcoma | .m | 2 to 1507 | 1 to 1506 | exact | available from MGC, AAA | | 1506/1506 (100 %) | 0 diff (100 %id) |
BI827726 | brain, medulla | .m | 17 to 820 | 1 to 810 | | | | 810/869 (93 %) | 15 diff (98.3 %id) |
TI_57171980 | | .m | 18 to 820 | 69 to 877 | | | | 809/936 (86 %) | 18 diff (98.1 %id) |
BX354889 | Neuroblastoma Cot 25-normalized | .n | 1 to 1003 | 1 to 990 | | tiling clone, | | 990/1044 (94 %) | 15 diff (98.6 %id) |
NM_006645.2 | | .n | 1 to 1988 | 1 to 1988 | exact | RefSeq, | | 1988/1988 (100 %) | 0 diff (100 %id) |
CD244430 | testis | .n | 25 to 840 | 1 to 816 | | | | 816/860 (94 %) | 7 diff (99.2 %id) |
TI_57172938 | | .n | 32 to 792 | 58 to 815 | | | | 758/815 (93 %) | 16 diff (98.1 %id) |
BI829404 | brain, medulla | .n | 56 to 828 | 1 to 779 | | | | 779/901 (86 %) | 21 diff (97.7 %id) |
TI_57176844 | | .n | 56 to 828 | 73 to 851 | | | | 779/973 (80 %) | 21 diff (97.9 %id) |
BX331933 | Neuroblastoma Cot 25-normalized | .n | 63 to 910 | 1 to 848 | | | | 848/848 (100 %) | 3 diff (99.7 %id) |
BM548285 | brain, hippocampus | .n | 69 to 983 | 12 to 930 | | | | 919/1058 (86 %) | 26 diff (97.6 %id) |
BF345998 | anaplastic oligodendroglioma with 1p/19qloss, brain | .n | 79 to 839 | 1 to 766 | | | | 766/864 (88 %) | 22 diff (97.5 %id) |
BI830644 | brain, medulla | .n | 79 to 982 | 1 to 907 | | | | 907/1117 (81 %) | 17 diff (98.5 %id) |
TI_57171192 | | .n | 79 to 982 | 35 to 941 | | | | 907/1151 (78 %) | 19 diff (98.4 %id) |
BX374921 | Neuroblastoma Cot 25-normalized | .n | 80 to 889 | 1 to 810 | | | | 810/810 (100 %) | 4 diff (99.6 %id) |
CD359607 | testis | .n | 80 to 886 | 1 to 811 | | | | 811/889 (91 %) | 18 diff (98.0 %id) |
TI_57171737 | | .n | 82 to 831 | 70 to 825 | | | | 756/938 (80 %) | 28 diff (97.1 %id) |
AK095668 | brain | .n | 85 to 1987 | 1 to 1903 | D142N | tiling clone, available from FLJ, | | 1903/1903 (100 %) | 2 diff (99.9 %id) |
BX387867 | | .n | 85 to 881 | 10 to 805 | | tiling clone, | | 796/805 (98 %) | 7 diff (99.2 %id) |
BM554217 | brain, medulla | .n | 85 to 1053 | 1 to 971 | | | | 971/992 (97 %) | 27 diff (97.3 %id) |
TI_57171999 | | .n | 86 to 834 | 60 to 808 | | | | 749/1037 (72 %) | 6 diff (99.5 %id) |
CD243701 | testis | .n | 94 to 813 | 8 to 729 | | | | 722/868 (83 %) | 10 diff (98.9 %id) |
BI827632 | brain, medulla | .n | 96 to 879 | 1 to 784 | | | | 784/968 (80 %) | 25 diff (97.5 %id) |
TI_57177110 | | .n | 101 to 921 | 60 to 873 | | | | 814/875 (93 %) | 13 diff (98.6 %id) |
TI_57233191 | | .n | 107 to 974 | 68 to 934 | | | | 867/935 (92 %) | 19 diff (98.0 %id) |
BI831063 | brain, medulla | .n | 110 to 921 | 1 to 805 | | | | 805/807 (99 %) | 12 diff (98.6 %id) |
BI906744 | leukocyte | .n | 110 to 974 | 1 to 864 | | | | 864/865 (99 %) | 18 diff (98.0 %id) |
BI827721 | brain, medulla | .n | 117 to 945 | 1 to 827 | | | | 827/827 (100 %) | 13 diff (98.5 %id) |
TI_57171975 | | .n | 117 to 945 | 36 to 862 | | | | 827/862 (95 %) | 16 diff (98.2 %id) |
BI915173 | brain | .n | 126 to 921 | 1 to 794 | | | | 794/797 (99 %) | 12 diff (98.5 %id) |
TI_57239188 | | .n | 126 to 921 | 31 to 824 | | | | 794/827 (96 %) | 10 diff (98.8 %id) |
TI_57241414 | | .n | 126 to 994 | 34 to 905 | | | | 872/908 (96 %) | 23 diff (97.5 %id) |
BI913651 | brain | .n | 127 to 994 | 1 to 871 | | | | 871/874 (99 %) | 20 diff (97.8 %id) |
TI_57176465 | | .n | 248 to 895 | 21 to 672 | | | | 652/674 (96 %) | 16 diff (97.7 %id) |
AF151810 | | .n | 459 to 1878 | 1 to 1414 | exact | | | 1414/1414 (100 %) | 9 diff (99.4 %id) |
TI_57184202 | | .n | 826 to 1728 | 27 to 934 | | | | 916/935 (97 %) | 28 diff (97.1 %id) |
BI767962 | pooled lung and spleen | .n | 828 to 1728 | 1 to 899 | | | | 899/900 (99 %) | 20 diff (97.8 %id) |
BE063234 | breast | .n | 833 to 1300 | 525 to 58 | | | Submitted on the opposite strand | 468/533 (87 %) | 3 diff (99.5 %id) |
BI835619 | pooled pancreas and spleen | .n | 848 to 1631 | 1 to 782 | | | | 782/783 (99 %) | 4 diff (99.5 %id) |
TI_57167219 | | .n | 848 to 1631 | 38 to 819 | | | | 782/820 (95 %) | 9 diff (99.0 %id) |
BG328760 | adenocarcinoma cell line, colon | .n | 851 to 1508 | 1 to 656 | | | | 656/657 (99 %) | 4 diff (99.4 %id) |
BM854487 | Ascites, stomach | .n | 879 to 1300 | 1 to 422 | | | | 422/422 (100 %) | 0 diff (100 %id) |
BI836638 | pooled pancreas and spleen | .n | 887 to 1611 | 1 to 725 | | | | 725/725 (100 %) | 4 diff (99.5 %id) |
TI_57167470 | | .n | 887 to 1611 | 65 to 789 | | | | 725/789 (91 %) | 7 diff (99.2 %id) |
AW748318 | breast | .n | 891 to 1141 | 267 to 12 | | | | 256/267 (95 %) | 0 diff (100 %id) |
BG469483 | adenocarcinoma cell line, colon | .n | 905 to 1783 | 1 to 892 | | | | 892/931 (95 %) | 31 diff (96.7 %id) |
BI766787 | pooled lung and spleen | .n | 910 to 1664 | 1 to 762 | | | | 762/762 (100 %) | 12 diff (98.5 %id) |
TI_57180844 | | .n | 910 to 1664 | 65 to 826 | | | | 762/826 (92 %) | 20 diff (97.6 %id) |
CD623056 | | .n | 911 to 1612 | 1 to 702 | | | | 700/708 (98 %) | 11 diff (98.5 %id) |
CD623057 | | .n | 911 to 1613 | 709 to 6 | | | | 704/709 (99 %) | 1 diff (99.9 %id) |
CA454636 | | .n | 915 to 1689 | 1 to 783 | | | | 783/887 (88 %) | 25 diff (97.2 %id) |
BM552608 | astrocytoma grade IV, cell line, brain | .n | 919 to 1732 | 1 to 816 | | | | 816/1042 (78 %) | 12 diff (98.9 %id) |
TI_1948224710 | | .n | 943 to 1819 | 1010 to 128 | | | | 883/1269 (69 %) | 25 diff (98.1 %id) |
TI_1948224708 | | .n | 944 to 1749 | 135 to 937 | | | | 803/1379 (58 %) | 28 diff (98.0 %id) |
TI_1948224709 | | .n | 944 to 1733 | 126 to 920 | | | | 795/1160 (68 %) | 22 diff (98.2 %id) |
TI_1948224711 | | .n | 944 to 1819 | 1007 to 129 | | | | 879/1162 (75 %) | 10 diff (99.2 %id) |
TI_1948225018 | | .n | 944 to 1715 | 128 to 900 | | | | 773/1424 (54 %) | 35 diff (97.6 %id) |
TI_1948225019 | | .n | 944 to 1646 | 129 to 841 | | | | 713/1262 (56 %) | 24 diff (98.1 %id) |
TI_1948225345 | | .n | 944 to 1181 | 123 to 360 | | | | 238/264 (90 %) | 6 diff (97.8 %id) |
TI_1948225346 | | .n | 944 to 1716 | 126 to 905 | | | | 780/1237 (63 %) | 26 diff (97.9 %id) |
TI_1948225348 | | .n | 944 to 1819 | 1007 to 127 | | | | 881/1214 (72 %) | 18 diff (98.6 %id) |
TI_1948225672 | | .n | 944 to 1704 | 127 to 890 | | | | 764/1433 (53 %) | 23 diff (98.4 %id) |
TI_1948225673 | | .n | 944 to 1515 | 125 to 698 | | | | 574/1282 (44 %) | 26 diff (98.0 %id) |
EL735953 | mixed | .n | 945 to 1589 | 1 to 643 | | | | 643/643 (100 %) | 5 diff (99.3 %id) |
TI_1948225021 | | .n | 945 to 1819 | 1007 to 124 | | | | 884/1210 (73 %) | 26 diff (97.9 %id) |
BI761736 | pooled colon, kidney, stomach | .n | 955 to 1815 | 1 to 867 | | | | 867/869 (99 %) | 18 diff (98.0 %id) |
TI_57149361 | | .n | 955 to 1815 | 34 to 900 | | | | 867/902 (96 %) | 24 diff (97.4 %id) |
BG820876 | anaplastic oligodendroglioma with 1p/19qloss, brain | .n | 957 to 1719 | 5 to 774 | | | | 768/821 (93 %) | 17 diff (98.0 %id) |
BG385910 | adenocarcinoma cell line, colon | .n | 980 to 1671 | 1 to 690 | | | | 690/690 (100 %) | 2 diff (99.8 %id) |
BM509819 | Pancreas, Purified pancreatic islet | .n | 990 to 1577 | 1 to 588 | | | | 588/588 (100 %) | 0 diff (100 %id) |
BG469832 | adenocarcinoma cell line, colon | .n | 1003 to 1798 | 1 to 796 | | | | 796/810 (98 %) | 9 diff (98.9 %id) |
BM689090 | eye, optic nerve | .n | 1020 to 1501 | 8 to 489 | | | | 482/489 (98 %) | 6 diff (98.8 %id) |
AA159464 | Pancreas | .n | 1026 to 1117 | 1 to 92 | | | | 92/92 (100 %) | 0 diff (100 %id) |
BG984820 | colon_normal | .n | 1029 to 1461 | 434 to 1 | | | | 434/434 (100 %) | 2 diff (99.6 %id) |
TI_1948225347 | | .n | 1066 to 1819 | 880 to 126 | | | | 755/1330 (56 %) | 8 diff (99.4 %id) |
BF809105 | colon_ins | .n | 1072 to 1300 | 235 to 6 | | | Submitted on the opposite strand | 230/235 (97 %) | 0 diff (100 %id) |
EL955429 | eyeball | .n | 1084 to 1672 | 1 to 589 | | | | 589/589 (100 %) | 2 diff (99.7 %id) |
AA307856 | colon | .n | 1105 to 1323 | 1 to 219 | | | | 219/219 (100 %) | 0 diff (100 %id) |
CA866534 | Pancreas, Purified pancreatic islet | .n | 1121 to 1552 | 10 to 441 | | fully sequenced, | | 432/441 (97 %) | 0 diff (100 %id) |
BE075593 | breast | .n | 1122 to 1473 | 361 to 10 | | | Submitted on the opposite strand | 352/361 (97 %) | 1 diff (99.8 %id) |
BG481443 | choriocarcinoma, placenta | .n | 1123 to 1988 | 1 to 880 | | | | 880/913 (96 %) | 12 diff (98.7 %id) |
R23890 | placenta | .n | 1134 to 1497 | 1 to 369 | | fully sequenced, | | 369/369 (100 %) | 3 diff (99.2 %id) |
R75983 | placenta | .n | 1134 to 1479 | 1 to 353 | | fully sequenced, | | 353/353 (100 %) | 3 diff (99.2 %id) |
CB128701 | Liver | .n | 1150 to 1752 | 7 to 609 | | | | 604/609 (99 %) | 6 diff (99.1 %id) |
AI539386 | pooled | .n | 1151 to 1878 | 727 to 1 | | | | 727/774 (93 %) | 14 diff (98.2 %id) |
TI_1948225020 | | .n | 1156 to 1819 | 794 to 126 | | | | 669/1380 (48 %) | 7 diff (99.5 %id) |
BF804845 | colon_ins | .n | 1161 to 1470 | 315 to 8 | | | Submitted on the opposite strand | 308/315 (97 %) | 1 diff (99.7 %id) |
BF806184 | colon_ins | .n | 1161 to 1470 | 317 to 10 | | | Submitted on the opposite strand | 308/317 (97 %) | 1 diff (99.7 %id) |
BM008731 | adenocarcinoma, Pancreas | .n | 1167 to 1984 | 1 to 814 | | | | 814/816 (99 %) | 7 diff (99.2 %id) |
CA487812 | | .n | 1167 to 1887 | 1 to 734 | | | | 734/821 (89 %) | 29 diff (96.5 %id) |
TI_59386443 | | .n | 1168 to 1984 | 62 to 874 | | | | 813/815 (99 %) | 6 diff (99.3 %id) |
AA868538 | | .n | 1170 to 1877 | 707 to 1 | | | | 707/707 (100 %) | 10 diff (98.6 %id) |
AI190303 | | .n | 1170 to 1854 | 685 to 1 | | | | 685/685 (100 %) | 7 diff (99.0 %id) |
AI345954 | adenocarcinoma, colon | .n | 1170 to 1854 | 686 to 1 | | | | 686/686 (100 %) | 8 diff (98.9 %id) |
BF435375 | pooled | .n | 1176 to 1878 | 703 to 1 | | | | 703/703 (100 %) | 10 diff (98.6 %id) |
AI219986 | pooled | .n | 1177 to 1854 | 678 to 1 | | | | 678/679 (99 %) | 7 diff (99.0 %id) |
TI_154055156 | | .n | 1180 to 1987 | 877 to 87 | | AAA | | 791/964 (82 %) | 27 diff (97.2 %id) |
BE796271 | lung, small cell carcinoma | .n | 1182 to 1972 | 1 to 785 | | | | 785/890 (88 %) | 15 diff (98.4 %id) |
W79084 | heart | .n | 1203 to 1552 | 1 to 351 | | fully sequenced, | | 351/351 (100 %) | 1 diff (99.8 %id) |
TI_151744392 | | .n | 1207 to 1878 | 719 to 48 | | tiling clone, | | 672/1040 (64 %) | 3 diff (99.8 %id) |
BF109507 | pooled | .n | 1210 to 1869 | 660 to 1 | | | | 660/661 (99 %) | 15 diff (97.8 %id) |
BM694878 | eye, RPE and Choroid | .n | 1213 to 1641 | 1 to 429 | | | | 429/429 (100 %) | 0 diff (100 %id) |
AW371415 | breast | .n | 1218 to 1635 | 418 to 1 | | | | 418/418 (100 %) | 3 diff (99.3 %id) |
BM353602 | Pancreas, Purified pancreatic islet | .n | 1224 to 1878 | 658 to 1 | | | | 658/658 (100 %) | 5 diff (99.3 %id) |
AA393148 | | .n | 1227 to 1552 | 1 to 326 | | fully sequenced, | | 326/326 (100 %) | 0 diff (100 %id) |
N57044 | placenta | .n | 1230 to 1434 | 1 to 205 | | fully sequenced, | | 205/205 (100 %) | 0 diff (100 %id) |
TI_151700904 | | .n | 1231 to 1878 | 698 to 52 | | | | 647/1050 (61 %) | 5 diff (99.6 %id) |
H03862 | placenta | .n | 1234 to 1536 | 1 to 303 | | | | 303/303 (100 %) | 0 diff (100 %id) |
BI837790 | pooled pancreas and spleen | .n | 1235 to 1843 | 1 to 611 | | | | 611/640 (95 %) | 12 diff (98.2 %id) |
TI_57165353 | | .n | 1235 to 1895 | 32 to 695 | | | | 664/770 (86 %) | 25 diff (96.8 %id) |
TI_151736226 | | .n | 1236 to 1878 | 704 to 59 | | | | 646/1183 (54 %) | 24 diff (98.0 %id) |
BM743478 | Ascites, stomach | .n | 1238 to 1824 | 1 to 588 | | | | 588/588 (100 %) | 1 diff (99.9 %id) |
BM767385 | Ascites, stomach | .n | 1238 to 1401 | 1 to 164 | | | | 164/164 (100 %) | 0 diff (100 %id) |
BM825119 | Ascites, stomach | .n | 1238 to 1752 | 1 to 515 | | | | 515/515 (100 %) | 0 diff (100 %id) |
BM696040 | eye, human retina | .n | 1239 to 1738 | 1 to 500 | | | | 500/500 (100 %) | 0 diff (100 %id) |
AA436117 | | .n | 1251 to 1774 | 1 to 523 | | | | 523/524 (99 %) | 2 diff (99.7 %id) |
BF439496 | pooled | .n | 1254 to 1878 | 625 to 1 | | | | 625/625 (100 %) | 4 diff (99.4 %id) |
CA952517 | Pancreas, Purified pancreatic islet | .n | 1254 to 1812 | 559 to 1 | | | | 559/559 (100 %) | 0 diff (100 %id) |
AI309975 | 2 pooled tumors (clear cell type), Kidney | .n | 1257 to 1854 | 599 to 1 | | | | 599/599 (100 %) | 1 diff (99.9 %id) |
AA455577 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .n | 1263 to 1552 | 1 to 290 | | fully sequenced, | | 290/290 (100 %) | 1 diff (99.7 %id) |
CA418575 | Chondrosarcoma Grade II, Left Pelvis | .n | 1267 to 1987 | 735 to 19 | | AAA | | 717/719 (99 %) | 10 diff (98.7 %id) |
BM505404 | Pancreas, Purified pancreatic islet | .n | 1269 to 1878 | 614 to 2 | | | | 613/614 (99 %) | 4 diff (99.4 %id) |
BQ021682 | lung, Metastatic Chondrosarcoma | .n | 1269 to 1987 | 738 to 19 | | AAA | | 720/720 (100 %) | 10 diff (98.7 %id) |
TI_157611866 | | .n | 1300 to 1878 | 638 to 60 | | | | 579/648 (89 %) | 4 diff (99.4 %id) |
BG413470 | pooled | .n | 1308 to 1878 | 570 to 1 | | | | 570/570 (100 %) | 2 diff (99.7 %id) |
BG654638 | Pancreas, Purified pancreatic islet | .n | 1311 to 1878 | 569 to 2 | | | Submitted on the opposite strand | 568/569 (99 %) | 0 diff (100 %id) |
BF590075 | pooled | .n | 1311 to 1833 | 523 to 1 | | | | 523/523 (100 %) | 3 diff (99.5 %id) |
AI829710 | pooled | .n | 1312 to 1854 | 543 to 1 | | | | 543/543 (100 %) | 0 diff (100 %id) |
AW268605 | pooled | .n | 1312 to 1854 | 543 to 1 | | | | 543/543 (100 %) | 1 diff (99.9 %id) |
AI202768 | anaplastic oligodendroglioma, brain | .n | 1314 to 1854 | 541 to 1 | | | | 541/541 (100 %) | 0 diff (100 %id) |
AI436105 | pooled | .n | 1314 to 1854 | 540 to 1 | | | | 540/540 (100 %) | 1 diff (99.9 %id) |
R65986 | placenta | .n | 1315 to 1563 | 1 to 249 | | fully sequenced, | | 249/249 (100 %) | 0 diff (100 %id) |
AA865258 | 2 pooled tumors (clear cell type), Kidney | .n | 1317 to 1851 | 535 to 1 | | | | 535/535 (100 %) | 3 diff (99.5 %id) |
AI720044 | colon | .n | 1317 to 1878 | 562 to 1 | | | | 562/562 (100 %) | 0 diff (100 %id) |
BM850262 | stomach | .n | 1317 to 1706 | 1 to 390 | | | | 390/390 (100 %) | 0 diff (100 %id) |
AI808710 | pooled | .n | 1318 to 1854 | 537 to 1 | | | | 537/537 (100 %) | 0 diff (100 %id) |
BX089281 | whole brain | .n | 1320 to 1878 | 568 to 10 | | | Submitted on the opposite strand | 559/569 (98 %) | 0 diff (100 %id) |
AA885823 | carcinoid, lung | .n | 1326 to 1434 | 109 to 1 | | | | 109/109 (100 %) | 4 diff (96.4 %id) |
AI222787 | adenocarcinoma, colon | .n | 1326 to 1854 | 529 to 1 | | | | 529/529 (100 %) | 1 diff (99.9 %id) |
AI332422 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .n | 1326 to 1854 | 529 to 1 | | | | 529/529 (100 %) | 0 diff (100 %id) |
AI911731 | pooled | .n | 1326 to 1834 | 509 to 1 | | | | 509/509 (100 %) | 0 diff (100 %id) |
AI830140 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .n | 1327 to 1854 | 529 to 1 | | | | 529/529 (100 %) | 2 diff (99.7 %id) |
AI148589 | placenta | .n | 1330 to 1878 | 549 to 1 | | | | 549/549 (100 %) | 1 diff (99.9 %id) |
AI742423 | pooled | .n | 1330 to 1854 | 526 to 1 | | | | 526/528 (99 %) | 1 diff (99.9 %id) |
BG656275 | Pancreas, Purified pancreatic islet | .n | 1332 to 1872 | 540 to 1 | | | Submitted on the opposite strand | 540/540 (100 %) | 4 diff (99.3 %id) |
CX787266 | human embryonic stem cells | .n | 1333 to 1869 | 1 to 537 | | | | 537/537 (100 %) | 0 diff (100 %id) |
BE645179 | pooled | .n | 1343 to 1878 | 537 to 1 | | | | 537/537 (100 %) | 2 diff (99.7 %id) |
AI040961 | | .n | 1344 to 1854 | 511 to 1 | | | | 511/511 (100 %) | 0 diff (100 %id) |
AI091541 | pooled | .n | 1344 to 1878 | 535 to 1 | | | | 535/535 (100 %) | 1 diff (99.9 %id) |
AI536845 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .n | 1344 to 1870 | 527 to 1 | | | | 527/527 (100 %) | 4 diff (99.3 %id) |
AI991280 | colon, colonic mucosa from 3 patients with Crohn'sdisease | .n | 1345 to 1854 | 510 to 1 | | | | 510/510 (100 %) | 0 diff (100 %id) |
AW510912 | pooled | .n | 1347 to 1834 | 488 to 1 | | | | 488/488 (100 %) | 0 diff (100 %id) |
BG773767 | choriocarcinoma, placenta | .n | 1358 to 1978 | 1 to 627 | | | | 627/627 (100 %) | 4 diff (99.4 %id) |
AA748637 | germinal center B cell | .n | 1369 to 1806 | 438 to 1 | | | | 438/438 (100 %) | 0 diff (100 %id) |
AI684261 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .n | 1373 to 1879 | 507 to 1 | | | | 507/507 (100 %) | 0 diff (100 %id) |
BM856979 | stomach | .n | 1377 to 1835 | 1 to 459 | | | | 459/459 (100 %) | 0 diff (100 %id) |
BM829840 | stomach | .n | 1377 to 1786 | 1 to 410 | | | | 410/410 (100 %) | 0 diff (100 %id) |
N29346 | placenta | .n | 1378 to 1850 | 478 to 5 | | fully sequenced, | | 474/478 (99 %) | 4 diff (99.2 %id) |
BM850474 | stomach | .n | 1379 to 1864 | 1 to 486 | | | | 486/486 (100 %) | 0 diff (100 %id) |
BF109041 | pooled | .n | 1386 to 1878 | 493 to 1 | | | | 493/493 (100 %) | 0 diff (100 %id) |
AA883844 | pooled | .n | 1389 to 1459 | 73 to 3 | | | | 71/73 (97 %) | 0 diff (100 %id) |
AI083755 | anaplastic oligodendroglioma, brain | .n | 1389 to 1854 | 466 to 1 | | | | 466/466 (100 %) | 0 diff (100 %id) |
AI935008 | pooled | .n | 1395 to 1837 | 443 to 1 | | | | 443/443 (100 %) | 0 diff (100 %id) |
R76814 | placenta | .n | 1449 to 1818 | 373 to 1 | | fully sequenced, | | 373/373 (100 %) | 4 diff (99.0 %id) |
R23891 | placenta | .n | 1467 to 1851 | 389 to 4 | | fully sequenced, | | 386/389 (99 %) | 1 diff (99.8 %id) |
W74439 | heart | .n | 1491 to 1878 | 389 to 1 | | fully sequenced, | | 389/389 (100 %) | 3 diff (99.3 %id) |
AA435561 | | .n | 1491 to 1878 | 388 to 2 | | fully sequenced, | | 387/388 (99 %) | 0 diff (100 %id) |
AA456074 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .n | 1491 to 1850 | 360 to 1 | | fully sequenced, | | 360/360 (100 %) | 4 diff (98.9 %id) |
CA866802 | Pancreas, Purified pancreatic islet | .n | 1491 to 1842 | 353 to 1 | | fully sequenced, | | 353/353 (100 %) | 0 diff (100 %id) |
DB551913 | hippocampus | .n | 1522 to 1987 | 1 to 466 | | | Submitted on the opposite strand | 466/466 (100 %) | 1 diff (99.8 %id) |
DB565819 | hypothalamus | .n | 1524 to 1987 | 1 to 464 | | | Submitted on the opposite strand | 464/464 (100 %) | 0 diff (100 %id) |
R65987 | placenta | .n | 1533 to 1832 | 305 to 5 | | fully sequenced, | | 301/305 (98 %) | 0 diff (100 %id) |
BM009023 | adenocarcinoma, Pancreas | .n | 1540 to 1987 | 1 to 445 | | AAA | | 445/445 (100 %) | 4 diff (99.2 %id) |
TI_59386747 | | .n | 1541 to 1987 | 102 to 545 | | AAA | | 444/444 (100 %) | 3 diff (99.4 %id) |
AI826276 | normal prostate, Prostate | .n | 1549 to 1854 | 306 to 1 | | | | 306/306 (100 %) | 0 diff (100 %id) |
AW573290 | pooled | .n | 1549 to 1854 | 306 to 1 | | | | 306/306 (100 %) | 0 diff (100 %id) |
AW511157 | pooled | .n | 1550 to 1838 | 289 to 1 | | | | 289/289 (100 %) | 0 diff (100 %id) |
F37219 | pectoral muscle (after mastectomy) | .n | 1562 to 1869 | 1 to 308 | | | | 308/308 (100 %) | 0 diff (100 %id) |
DB377570 | placenta | .n | 1569 to 1987 | 418 to 1 | | | | 418/420 (99 %) | 13 diff (97.0 %id) |
AF039696 | colorectal carcinoma | .n | 1579 to 1985 | 201 to 604 | | | | 404/604 (66 %) | 11 diff (98.2 %id) |
AI149979 | | .n | 1579 to 1854 | 276 to 1 | | | | 276/276 (100 %) | 0 diff (100 %id) |
BG981880 | colon_normal | .n | 1588 to 1842 | 255 to 1 | | | | 255/255 (100 %) | 1 diff (99.7 %id) |
AI697358 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .n | 1589 to 1808 | 220 to 1 | | | | 220/220 (100 %) | 0 diff (100 %id) |
AI951457 | breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary | .n | 1589 to 1808 | 220 to 1 | | | | 220/220 (100 %) | 0 diff (100 %id) |
BF229556 | colon_est | .n | 1590 to 1756 | 166 to 1 | | | | 166/166 (100 %) | 5 diff (97.0 %id) |
BM842083 | lymph node, stomach | .n | 1601 to 1987 | 1 to 387 | | | | 387/400 (96 %) | 1 diff (99.8 %id) |
D60944 | | .n | 1621 to 1987 | 1 to 365 | | | | 365/365 (100 %) | 2 diff (99.5 %id) |
D61030 | | .n | 1621 to 1987 | 1 to 364 | | | | 364/364 (100 %) | 4 diff (99.0 %id) |
BM726671 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .n | 1631 to 1983 | 1 to 353 | | | | 353/353 (100 %) | 0 diff (100 %id) |
F29301 | pectoral muscle (after mastectomy) | .n | 1656 to 1869 | 1 to 214 | | | | 214/214 (100 %) | 0 diff (100 %id) |
BI905871 | leukocyte | .n | 1659 to 1867 | 1 to 209 | | | | 209/209 (100 %) | 0 diff (100 %id) |
AI391496 | B-cell, chronic lymphotic leukemia | .n | 1661 to 1860 | 200 to 1 | | | | 200/200 (100 %) | 0 diff (100 %id) |
BF223824 | pooled germ cell tumors | .n | 1661 to 1860 | 200 to 1 | | | | 200/200 (100 %) | 0 diff (100 %id) |
EC456735 | Prostate | .n | 1666 to 1748 | 16 to 100 | | | | 85/100 (85 %) | 6 diff (94.0 %id) |
CA430940 | cell lines, Chondrosarcoma | .n | 1688 to 1987 | 318 to 19 | | AAA | | 300/300 (100 %) | 0 diff (100 %id) |
AI867664 | Prostate | .n | 1893 to 1974 | 1 to 82 | | | Submitted on the opposite strand | 82/82 (100 %) | 0 diff (100 %id) |
BC035482 | Brain, adult medulla | .o | 1 to 1678 | 1 to 1678 | exact | tiling clone, available from MGC, | | 1678/1678 (100 %) | 0 diff (100 %id) |
DA512644 | brain | .o | 24 to 694 | 2 to 672 | | capped | | 671/674 (99 %) | 4 diff (99.5 %id) |
DB316430 | brain | .o | 1314 to 1787 | 474 to 1 | | tiling clone, | | 474/558 (84 %) | 5 diff (99.2 %id) |
BM560591 | brain, medulla | .p | 1 to 732 | 10 to 739 | | | | 730/1125 (64 %) | 23 diff (98.0 %id) |
TI_57173822 | | .p | 7 to 732 | 29 to 754 | | tiling clone, | | 726/755 (96 %) | 7 diff (99.1 %id) |
BI825978 | brain, medulla | .p | 8 to 732 | 1 to 725 | | | | 725/726 (99 %) | 2 diff (99.8 %id) |
AI917501 | pooled germ cell tumors | .p | 9 to 286 | 290 to 13 | | tiling clone, | | 278/290 (95 %) | 1 diff (99.7 %id) |
AI631488 | pooled germ cell tumors | .p | 9 to 286 | 290 to 13 | | | | 278/290 (95 %) | 1 diff (99.7 %id) |
AW593802 | pooled germ cell tumors | .p | 9 to 254 | 246 to 1 | | | | 246/246 (100 %) | 1 diff (99.6 %id) |
AW589955 | pooled germ cell tumors | .p | 9 to 286 | 290 to 13 | | | | 278/290 (95 %) | 2 diff (99.4 %id) |
BI831103 | brain, medulla | .p | 53 to 846 | 1 to 792 | | tiling clone, | | 792/792 (100 %) | 4 diff (99.5 %id) |
TI_57177152 | | .p | 53 to 846 | 65 to 856 | | | | 792/856 (92 %) | 9 diff (99.0 %id) |
TI_57172199 | | .p | 82 to 732 | 102 to 750 | | | | 651/759 (85 %) | 13 diff (98.3 %id) |
BI831536 | brain, medulla | .p | 87 to 732 | 1 to 644 | | | | 646/653 (98 %) | 12 diff (98.2 %id) |
BM817533 | Ascites, stomach | .p | 473 to 989 | 1 to 517 | | tiling clone, | | 517/517 (100 %) | 0 diff (100 %id) |
CD626854 | | .q | 1 to 704 | 734 to 25 | V10G F22S Q23E Y29* | tiling clone, | | 710/734 (96 %) | 11 diff (98.6 %id) |
TI_57178770 | | .r | 1 to 703 | 27 to 733 | | tiling clone, | | 707/733 (96 %) | 10 diff (98.7 %id) |
AA732740 | | .r | 243 to 415 | 1 to 173 | | | Submitted on the opposite strand | 173/173 (100 %) | 5 diff (97.2 %id) |
TI_154139361 | | .r | 554 to 1204 | 81 to 730 | | tiling clone, | | 650/730 (89 %) | 17 diff (97.7 %id) |
AW402898 | lymph | .r | 561 to 1033 | 7 to 479 | | | | 473/479 (98 %) | 2 diff (99.6 %id) |
BG748319 | eye, normal pigmented retinal epithelium | .s | 1 to 642 | 1 to 640 | exact | tiling clone, | | 640/641 (99 %) | 7 diff (99.0 %id) |
AW752209 | colon | .t | 1 to 398 | 422 to 8 | | tiling clone, | | 407/427 (95 %) | 0 diff (100 %id) |
BF822647 | kidney_tumor | .t | 208 to 647 | 1 to 440 | | tiling clone, | | 440/440 (100 %) | 5 diff (98.9 %id) |
BE067411 | breast | .t | 552 to 768 | 221 to 4 | | tiling clone, | Submitted on the opposite strand | 218/221 (98 %) | 0 diff (100 %id) |
AA835882 | germinal center B cell | .t | 695 to 1128 | 432 to 1 | | tiling clone, | | 432/432 (100 %) | 4 diff (99.1 %id) |
AW043785 | pooled | .t | 750 to 1224 | 474 to 1 | | tiling clone, | | 474/474 (100 %) | 0 diff (100 %id) |
BU069153 | Pancreas, Purified pancreatic islet | .t | 752 to 1189 | 438 to 1 | | | | 438/438 (100 %) | 0 diff (100 %id) |
AI243219 | pooled | .t | 756 to 1224 | 469 to 1 | | | | 469/469 (100 %) | 0 diff (100 %id) |
AI318065 | adenocarcinoma, colon | .t | 759 to 1200 | 442 to 1 | | | | 442/442 (100 %) | 0 diff (100 %id) |
AI833323 | colon | .t | 764 to 1224 | 461 to 1 | | | | 461/461 (100 %) | 0 diff (100 %id) |
AI799122 | pooled | .t | 765 to 1200 | 436 to 1 | | | | 436/436 (100 %) | 0 diff (100 %id) |
AW166483 | cervix | .t | 766 to 1200 | 435 to 1 | | | | 435/435 (100 %) | 0 diff (100 %id) |
AI679583 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .t | 768 to 1216 | 449 to 1 | | | | 449/449 (100 %) | 0 diff (100 %id) |
BU629722 | cell lines, Chondrosarcoma | .t | 768 to 1333 | 584 to 19 | | AAA | | 566/566 (100 %) | 2 diff (99.7 %id) |
AI347903 | 2 pooled tumors (clear cell type), Kidney | .t | 771 to 1200 | 430 to 1 | | | | 430/430 (100 %) | 0 diff (100 %id) |
BM996031 | lung, Metastatic Chondrosarcoma | .t | 776 to 1333 | 576 to 19 | | tiling clone, AAA | | 558/558 (100 %) | 0 diff (100 %id) |
AW183835 | pooled | .t | 777 to 1200 | 424 to 1 | | | | 424/424 (100 %) | 0 diff (100 %id) |
AW188625 | colon, moderately differentiated adenocarcinoma | .t | 779 to 1218 | 440 to 1 | | | | 440/440 (100 %) | 0 diff (100 %id) |
AI858097 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .t | 780 to 1200 | 421 to 1 | | | | 421/421 (100 %) | 0 diff (100 %id) |
AI276559 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .t | 781 to 1200 | 420 to 1 | | | | 420/420 (100 %) | 0 diff (100 %id) |
AI301012 | 2 pooled tumors (clear cell type), Kidney | .t | 781 to 1200 | 420 to 1 | | | | 420/420 (100 %) | 0 diff (100 %id) |
BQ355503 | head_neck | .t | 794 to 1117 | 332 to 8 | | | | 325/332 (97 %) | 0 diff (100 %id) |
AI377383 | pooled | .t | 804 to 1200 | 397 to 1 | | | | 397/397 (100 %) | 0 diff (100 %id) |
BF109113 | pooled | .t | 805 to 1206 | 402 to 1 | | | | 402/402 (100 %) | 0 diff (100 %id) |
AW082764 | pooled | .t | 807 to 1200 | 394 to 1 | | | | 394/394 (100 %) | 0 diff (100 %id) |
AA777492 | liver and spleen | .t | 822 to 1331 | 516 to 1 | | | | 516/516 (100 %) | 18 diff (96.6 %id) |
AI220007 | pooled | .t | 826 to 1200 | 375 to 1 | | | | 375/375 (100 %) | 0 diff (100 %id) |
AW166434 | cervix | .t | 826 to 1200 | 375 to 1 | | | | 375/375 (100 %) | 0 diff (100 %id) |
BP397661 | pancreatic islet | .t | 831 to 1333 | 1 to 503 | | | Submitted on the opposite strand | 503/503 (100 %) | 0 diff (100 %id) |
AI762065 | colon, colon tumor, RER+ | .t | 843 to 1200 | 358 to 1 | | | | 358/358 (100 %) | 0 diff (100 %id) |
AW518289 | adenocarcinoma, Pancreas | .t | 859 to 1226 | 368 to 1 | | | | 368/368 (100 %) | 0 diff (100 %id) |
AI160545 | uterus | .t | 861 to 1224 | 364 to 1 | | | | 364/364 (100 %) | 0 diff (100 %id) |
AI272123 | Kidney | .t | 862 to 1187 | 326 to 1 | | | | 326/326 (100 %) | 0 diff (100 %id) |
AW592847 | pooled | .t | 862 to 1200 | 339 to 1 | | | | 339/339 (100 %) | 0 diff (100 %id) |
BF846450 | lung_normal | .u | 1 to 389 | 1 to 388 | | | | 388/388 (100 %) | 6 diff (98.5 %id) |
AI968585 | pooled germ cell tumors | .u | 5 to 440 | 17 to 452 | | tiling clone, | Submitted on the opposite strand | 436/452 (96 %) | 6 diff (98.7 %id) |
BF770538 | epid_tumor | .u | 91 to 518 | 429 to 1 | | tiling clone, | Submitted on the opposite strand | 429/429 (100 %) | 3 diff (99.4 %id) |
EL946120 | eyeball | .u | 103 to 449 | 22 to 368 | | | | 347/368 (94 %) | 2 diff (99.5 %id) |
BI023549 | marrow | .u | 198 to 512 | 15 to 330 | | tiling clone, | | 316/330 (95 %) | 11 diff (96.7 %id) |
BG999197 | head_neck | .va | 1 to 484 | 19 to 504 | | tiling clone, | | 486/505 (96 %) | 6 diff (98.9 %id) |
BI006487 | kidney_tumor | .va | 23 to 475 | 1 to 453 | | tiling clone, | | 453/453 (100 %) | 21 diff (95.4 %id) |
BI006541 | kidney_tumor | .va | 26 to 491 | 15 to 475 | | tiling clone, | | 461/477 (96 %) | 24 diff (95.0 %id) |
BF900932 | marrow | .va | 138 to 613 | 3 to 480 | | | | 478/480 (99 %) | 6 diff (98.8 %id) |
BF893810 | marrow | .va | 145 to 390 | 39 to 284 | | | | 246/284 (86 %) | 6 diff (97.9 %id) |
BI061077 | uterus_tumor | .va | 154 to 261 | 108 to 1 | | | | 108/108 (100 %) | 0 diff (100 %id) |
TI_57234679 | | .va | 422 to 1037 | 33 to 644 | | | | 612/644 (95 %) | 7 diff (99.0 %id) |
BI908834 | leukocyte | .va | 429 to 1037 | 1 to 605 | | tiling clone, | | 605/605 (100 %) | 4 diff (99.4 %id) |
BF819476 | kidney_tumor | .va | 563 to 858 | 312 to 17 | | tiling clone, | Submitted on the opposite strand | 296/328 (90 %) | 0 diff (100 %id) |
AW577225 | breast | .va | 647 to 1201 | 1 to 553 | | | | 553/553 (100 %) | 6 diff (99.0 %id) |
R71556 | placenta | .va | 774 to 1103 | 1 to 330 | | | | 330/333 (99 %) | 4 diff (98.8 %id) |
BI199808 | brain, neuroblastoma | .va | 785 to 1710 | 1 to 924 | | tiling clone, | | 924/952 (97 %) | 30 diff (96.9 %id) |
BF974897 | B-cells, primary B-cells from tonsils (cell line) | .va | 806 to 1527 | 1 to 717 | | | | 717/721 (99 %) | 9 diff (98.8 %id) |
BF975084 | B-cells, primary B-cells from tonsils (cell line) | .va | 806 to 1448 | 1 to 643 | | | | 643/643 (100 %) | 1 diff (99.9 %id) |
BQ644693 | hepatocellular carcinoma, cell line, Liver | .va | 818 to 1663 | 1 to 855 | | tiling clone, | | 855/932 (91 %) | 33 diff (96.5 %id) |
BM700420 | eye, lens | .va | 841 to 1415 | 1 to 574 | | | | 574/574 (100 %) | 1 diff (99.9 %id) |
BF530109 | anaplastic oligodendroglioma with 1p/19qloss, brain | .va | 853 to 1669 | 1 to 824 | | tiling clone, | | 824/930 (88 %) | 59 diff (93.7 %id) |
DB294735 | | .vb | 1 to 802 | 2 to 808 | | tiling clone, capped | | 807/812 (99 %) | 10 diff (98.8 %id) |
DB384893 | | .vb | 1642 to 2208 | 564 to 1 | | tiling clone, | | 564/568 (99 %) | 15 diff (97.4 %id) |
BU151428 | melanotic melanoma, cell line, skin | .vb | 1939 to 2566 | 1 to 626 | | | | 626/904 (69 %) | 31 diff (96.6 %id) |
BQ682502 | melanotic melanoma, cell line, skin | .vb | 1939 to 2834 | 1 to 901 | | tiling clone, | | 901/901 (100 %) | 20 diff (97.8 %id) |
BQ678127 | melanotic melanoma, cell line, skin | .vb | 1940 to 2866 | 1 to 933 | | tiling clone, | | 933/933 (100 %) | 21 diff (97.8 %id) |
BU074881.
matches multiple genes | Pancreas, Purified pancreatic islet | .vc | 1 to 622 | 1 to 622 | | tiling clone, | also hits gene RPS25P6 | 622/623 (99 %) | 4 diff (99.4 %id) |
CB161101 | Liver | .vc | 275 to 872 | 1 to 598 | | | | 598/598 (100 %) | 0 diff (100 %id) |
BF819493 | kidney_tumor | .vc | 309 to 893 | 10 to 595 | | | | 586/603 (97 %) | 11 diff (98.2 %id) |
AI827995 | pooled | .vc | 446 to 1001 | 556 to 1 | | | | 556/556 (100 %) | 0 diff (100 %id) |
AI807471 | pooled | .vc | 447 to 1001 | 555 to 1 | | | | 555/555 (100 %) | 1 diff (99.9 %id) |
BM696789 | eye, lens | .vc | 470 to 895 | 1 to 426 | | | | 426/426 (100 %) | 0 diff (100 %id) |
AI025986 | parathyroid gland, parathyroid tumor | .vc | 506 to 1021 | 516 to 4 | | | | 513/516 (99 %) | 4 diff (99.3 %id) |
AI031908 | parathyroid gland, parathyroid tumor | .vc | 522 to 1001 | 480 to 1 | | | | 480/480 (100 %) | 7 diff (98.6 %id) |
AI291760 | carcinoid, lung | .vc | 522 to 1001 | 480 to 1 | | | | 480/480 (100 %) | 2 diff (99.6 %id) |
AI311479 | 2 pooled tumors (clear cell type), Kidney | .vc | 553 to 1025 | 473 to 1 | | | | 473/473 (100 %) | 2 diff (99.6 %id) |
AI198119 | anaplastic oligodendroglioma, brain | .vc | 561 to 1001 | 436 to 1 | | | | 436/439 (99 %) | 12 diff (97.3 %id) |
AI083851 | anaplastic oligodendroglioma, brain | .vc | 575 to 1025 | 451 to 1 | | tiling clone, | | 451/451 (100 %) | 0 diff (100 %id) |
AI289227 | 2 pooled tumors (clear cell type), Kidney | .vc | 592 to 1001 | 412 to 1 | | | | 412/412 (100 %) | 13 diff (96.9 %id) |
AA969436 | pooled | .vc | 621 to 998 | 378 to 1 | | | | 378/378 (100 %) | 0 diff (100 %id) |
BM796890 | Ascites, stomach | .vc | 666 to 1132 | 1 to 467 | | tiling clone, AAA | | 467/467 (100 %) | 5 diff (99.0 %id) |
AI216504 | pooled | .vc | 669 to 1001 | 333 to 1 | | | | 335/335 (100 %) | 0 diff (100 %id) |
AI243242 | pooled | .vc | 669 to 1025 | 357 to 1 | | | | 360/360 (100 %) | 0 diff (100 %id) |
F26502 | pectoral muscle (after mastectomy) | .vc | 717 to 784 | 1 to 68 | | | | 68/68 (100 %) | 0 diff (100 %id) |
BU735301 | eye, lens | .vc | 1030 to 1134 | 123 to 19 | | tiling clone, AAA | | 105/105 (100 %) | 0 diff (100 %id) |
BI008965 | kidney_tumor | .vd | 1 to 514 | 1 to 513 | N2T I5S R6E E7R K8R ... | tiling clone, | | 513/513 (100 %) | 17 diff (96.7 %id) |
DA925170 | small intestine | .ve | 1 to 578 | 2 to 581 | R107P T109D V110S N111Q A112R ... | tiling clone, capped | | 580/580 (100 %) | 3 diff (99.5 %id) |
BG960003 | colon | .ve | 398 to 829 | 437 to 11 | | tiling clone, | | 427/437 (97 %) | 0 diff (100 %id) |
AW367098 | head_neck | .ve | 399 to 782 | 387 to 3 | | tiling clone, | | 385/387 (99 %) | 0 diff (100 %id) |
AW849264 | colon | .ve | 399 to 783 | 1 to 385 | | | | 385/385 (100 %) | 4 diff (99.0 %id) |
BF899222 | marrow | .vf-u | 1 to 197 | 199 to 4 | | tiling clone, | Submitted on the opposite strand | 196/201 (97 %) | 0 diff (100 %id) |
BC127799 | PCR rescued clones, C list | .vf-u | 40 to 836 | 802 to 6 | | tiling clone, | Submitted on the opposite strand | 797/804 (99 %) | 0 diff (100 %id) |
BC150585 | PCR rescued clones, C list | .vf-u | 40 to 836 | 802 to 6 | | | Submitted on the opposite strand | 797/804 (99 %) | 0 diff (100 %id) |
BI024781 | marrow | .vf-u | 121 to 643 | 541 to 20 | | | | 522/541 (96 %) | 0 diff (100 %id) |
BF884631 | lung_tumor | .vf-u | 229 to 386 | 1 to 159 | | | | 159/159 (100 %) | 5 diff (96.9 %id) |
CV311567 | marrow | .vf-u | 230 to 431 | 14 to 220 | | | | 207/220 (94 %) | 6 diff (97.3 %id) |
BE064150 | breast | .vf-u | 506 to 684 | 197 to 20 | | | Submitted on the opposite strand | 178/205 (86 %) | 0 diff (100 %id) |
BI047672 | stomach | .vf-u | 506 to 671 | 9 to 171 | | | | 163/171 (95 %) | 6 diff (96.5 %id) |
BI048227 | stomach | .vf-u | 506 to 629 | 25 to 144 | | | | 120/144 (83 %) | 6 diff (95.9 %id) |
CV357476 | stomach | .vf-u | 511 to 629 | 19 to 137 | | tiling clone, | | 119/137 (86 %) | 6 diff (95.7 %id) |
BI017150 | lung_tumor | .vf-u | 517 to 671 | 155 to 1 | | | | 155/155 (100 %) | 1 diff (99.4 %id) |
BI043920 | ovary | .vf-u | 517 to 677 | 183 to 23 | | | | 161/183 (87 %) | 0 diff (100 %id) |
BI047541 | stomach | .vf-u | 517 to 630 | 113 to 1 | | | | 113/113 (100 %) | 4 diff (96.5 %id) |
BI047829 | stomach | .vf-u | 517 to 626 | 1 to 110 | | | | 110/110 (100 %) | 5 diff (95.5 %id) |
BI048217 | stomach | .vf-u | 517 to 671 | 155 to 1 | | | | 155/155 (100 %) | 1 diff (99.4 %id) |
CV357409 | stomach | .vf-u | 517 to 671 | 155 to 1 | | | Submitted on the opposite strand | 155/155 (100 %) | 1 diff (99.4 %id) |
CV357430 | stomach | .vf-u | 517 to 677 | 166 to 6 | | | Submitted on the opposite strand | 161/166 (96 %) | 0 diff (100 %id) |
CV357233 | stomach | .vf-u | 528 to 629 | 1 to 103 | | | | 103/103 (100 %) | 2 diff (98.1 %id) |
AI885432 | anaplastic oligodendroglioma, brain | .vg-u | 1 to 524 | 526 to 1 | | tiling clone, | | 526/555 (94 %) | 2 diff (99.7 %id) |
AA579968 | colon | .vg-u | 87 to 525 | 440 to 1 | | | | 440/440 (100 %) | 0 diff (100 %id) |
AI189999 | placenta | .vg-u | 115 to 551 | 438 to 2 | | | | 437/438 (99 %) | 0 diff (100 %id) |
AA832163 | germinal center B cell | .vg-u | 127 to 521 | 394 to 1 | | | | 394/394 (100 %) | 4 diff (99.0 %id) |
BU687049 | lung, Primary Lung Epithelial Cells | .vg-u | 195 to 662 | 486 to 19 | S81F | tiling clone, AAA | | 468/468 (100 %) | 1 diff (99.8 %id) |
R72440 | breast | .vg-u | 197 to 479 | 282 to 1 | | | | 282/284 (99 %) | 3 diff (99.0 %id) |
AA442745 | | .vg-u | 199 to 550 | 349 to 3 | | | | 347/349 (99 %) | 0 diff (100 %id) |
DB445024 | testis | .vh | 1 to 613 | 1 to 428 | | tiling clone, | | 392/428 (91 %) | 26 diff (94.0 %id) |
BI018390 | marrow | .vh | 48 to 427 | 402 to 23 | | tiling clone, | | 380/402 (94 %) | 0 diff (100 %id) |
TI_157607654 | | .vi-u | 1 to 582 | 665 to 80 | V24L | tiling clone, | | 586/665 (88 %) | 0 diff (100 %id) |
BF058922 | fibrotheoma, ovary | .vi-u | 144 to 582 | 439 to 1 | V24L | | | 439/439 (100 %) | 2 diff (99.6 %id) |
AK000422 | | .vi-u | 265 to 683 | 1 to 419 | | available from FLJ, AAA | | 419/419 (100 %) | 1 diff (99.8 %id) |
DA029247 | | .vi-u | 266 to 841 | 2 to 577 | | capped | | 576/576 (100 %) | 3 diff (99.5 %id) |
DA065481 | cerebellum | .vi-u | 266 to 841 | 2 to 577 | | capped | | 576/576 (100 %) | 2 diff (99.7 %id) |
DA270917 | caudate nucleus | .vi-u | 266 to 818 | 2 to 554 | | capped | | 553/553 (100 %) | 2 diff (99.7 %id) |
DA273223 | caudate nucleus | .vi-u | 266 to 823 | 2 to 559 | | capped | | 558/558 (100 %) | 2 diff (99.7 %id) |
DA314156 | hippocampus | .vi-u | 266 to 791 | 2 to 527 | | capped | | 526/526 (100 %) | 1 diff (99.9 %id) |
DA350251 | substantia nigra | .vi-u | 266 to 834 | 2 to 570 | | tiling clone, capped | | 569/569 (100 %) | 2 diff (99.7 %id) |
DA502853 | brain | .vi-u | 266 to 820 | 2 to 557 | | capped | | 556/556 (100 %) | 3 diff (99.5 %id) |
DA701651 | | .vi-u | 266 to 794 | 2 to 530 | | capped | | 529/529 (100 %) | 2 diff (99.7 %id) |
DA702304 | | .vi-u | 266 to 794 | 2 to 528 | | capped | | 527/527 (100 %) | 4 diff (99.3 %id) |
DB167642 | kidney, tumor tissue | .vi-u | 266 to 842 | 2 to 579 | | capped | | 578/578 (100 %) | 2 diff (99.7 %id) |
TI_57150350 | | .vi-u | 278 to 586 | 31 to 338 | | | | 308/669 (46 %) | 5 diff (99.3 %id) |
TI_57150422 | | .vi-u | 278 to 586 | 29 to 336 | | | | 308/822 (37 %) | 5 diff (99.4 %id) |
BM671044 | eye, optic nerve | .vi-u | 285 to 687 | 421 to 19 | | AAA | | 403/412 (97 %) | 3 diff (99.3 %id) |
BM701881 | eye, optic nerve | .vi-u | 285 to 687 | 1 to 403 | | AAA | | 403/403 (100 %) | 3 diff (99.3 %id) |
AW328672.
matches multiple genes | cervix | .vi-u | 359 to 687 | 346 to 18 | | AAA | also hits gene POLR2G | 329/329 (100 %) | 0 diff (100 %id) |
AW328728.
matches multiple genes | cervix | .vi-u | 392 to 687 | 1 to 297 | | AAA | also hits gene POLR2G | 297/297 (100 %) | 3 diff (99.0 %id) |
BU729061 | eye, optic nerve | .vi-u | 486 to 687 | 220 to 19 | | AAA | | 202/202 (100 %) | 3 diff (98.6 %id) |
DB031154 | testis | .vi-u | 629 to 1225 | 2 to 598 | | capped | | 597/597 (100 %) | 0 diff (100 %id) |
DB039898 | testis | .vi-u | 632 to 1205 | 2 to 575 | | capped | | 574/574 (100 %) | 0 diff (100 %id) |
DB021429 | testis | .vi-u | 646 to 1218 | 2 to 574 | | capped | | 573/574 (99 %) | 2 diff (99.7 %id) |
DA089170 | cerebellum | .vi-u | 650 to 1178 | 2 to 530 | | capped | | 529/529 (100 %) | 1 diff (99.9 %id) |
DB044083 | testis | .vi-u | 650 to 1222 | 2 to 574 | | capped | | 573/573 (100 %) | 1 diff (99.9 %id) |
DB053577 | testis | .vi-u | 651 to 1214 | 2 to 565 | | capped | | 564/566 (99 %) | 1 diff (99.9 %id) |
DA097046 | cerebellum | .vi-u | 656 to 1206 | 2 to 552 | | capped | | 551/551 (100 %) | 0 diff (100 %id) |
DA141800 | alzheimer cortex | .vi-u | 656 to 1201 | 2 to 547 | | capped | | 546/546 (100 %) | 0 diff (100 %id) |
DA200139 | brain | .vi-u | 656 to 1240 | 2 to 586 | | capped | | 585/585 (100 %) | 0 diff (100 %id) |
DA274552 | corpus callosum | .vi-u | 656 to 1234 | 2 to 580 | | capped | | 579/579 (100 %) | 1 diff (99.9 %id) |
TI_57170783 | | .vi-u | 656 to 1266 | 30 to 639 | | | | 610/639 (95 %) | 6 diff (99.1 %id) |
DB023883 | testis | .vi-u | 656 to 1202 | 2 to 548 | | capped | | 547/547 (100 %) | 0 diff (100 %id) |
DB030658 | testis | .vi-u | 656 to 1250 | 2 to 596 | | capped | | 595/595 (100 %) | 1 diff (99.9 %id) |
DB034622 | testis | .vi-u | 656 to 1235 | 2 to 581 | | capped | | 580/580 (100 %) | 0 diff (100 %id) |
DB052354 | testis | .vi-u | 656 to 1205 | 2 to 551 | | capped | | 550/550 (100 %) | 0 diff (100 %id) |
DB081470 | testis | .vi-u | 656 to 1153 | 2 to 499 | | capped | | 498/498 (100 %) | 0 diff (100 %id) |
BI830095 | brain, medulla | .vi-u | 657 to 1266 | 1 to 610 | | | | 610/610 (100 %) | 1 diff (99.9 %id) |
DB028032 | testis | .vi-u | 660 to 1193 | 2 to 535 | | capped | | 534/534 (100 %) | 0 diff (100 %id) |
DA242783 | brain | .vi-u | 669 to 1230 | 2 to 563 | | capped | | 562/562 (100 %) | 1 diff (99.9 %id) |
DA410905 | thalamus | .vi-u | 669 to 1217 | 2 to 550 | | capped | | 549/549 (100 %) | 1 diff (99.9 %id) |
DB026106 | testis | .vi-u | 669 to 1232 | 2 to 565 | | capped | | 564/564 (100 %) | 0 diff (100 %id) |
DB039721 | testis | .vi-u | 669 to 1249 | 2 to 582 | | capped | | 581/581 (100 %) | 0 diff (100 %id) |
DB051099 | testis | .vi-u | 669 to 1241 | 2 to 574 | | capped | | 573/573 (100 %) | 1 diff (99.9 %id) |
BI912810 | brain | .vi-u | 674 to 1323 | 1 to 645 | | | | 645/645 (100 %) | 7 diff (99.0 %id) |
TI_57238067 | | .vi-u | 674 to 1323 | 29 to 673 | | | | 645/673 (95 %) | 6 diff (99.2 %id) |
DA310619 | hippocampus | .vi-u | 685 to 1267 | 2 to 584 | | tiling clone, capped | | 583/583 (100 %) | 0 diff (100 %id) |
DB021180 | testis | .vi-u | 685 to 1250 | 2 to 569 | | capped | | 568/568 (100 %) | 2 diff (99.7 %id) |
DB045698 | testis | .vi-u | 685 to 1238 | 2 to 555 | | capped | | 554/554 (100 %) | 1 diff (99.9 %id) |
DB047243 | testis | .vi-u | 685 to 1250 | 2 to 567 | | capped | | 566/566 (100 %) | 1 diff (99.9 %id) |
DB483039 | hippocampus | .vi-u | 691 to 1179 | 1 to 489 | | | | 489/489 (100 %) | 1 diff (99.8 %id) |
DB049173 | testis | .vi-u | 701 to 1261 | 2 to 562 | | capped | | 561/561 (100 %) | 3 diff (99.5 %id) |
DB028044 | testis | .vi-u | 702 to 1232 | 2 to 532 | | capped | | 531/531 (100 %) | 1 diff (99.9 %id) |
DB032318 | testis | .vi-u | 702 to 1302 | 2 to 603 | | capped | | 602/602 (100 %) | 2 diff (99.7 %id) |
DB041345 | testis | .vi-u | 702 to 1239 | 2 to 540 | | capped | | 539/539 (100 %) | 2 diff (99.7 %id) |
DB022913 | testis | .vi-u | 703 to 1256 | 2 to 556 | | capped | | 555/555 (100 %) | 3 diff (99.5 %id) |
DB027172 | testis | .vi-u | 703 to 1245 | 2 to 544 | | capped | | 543/543 (100 %) | 0 diff (100 %id) |
DB056424 | testis | .vi-u | 703 to 1243 | 2 to 543 | | capped | | 542/542 (100 %) | 1 diff (99.9 %id) |
DB058312 | testis | .vi-u | 703 to 1223 | 2 to 523 | | capped | | 522/522 (100 %) | 2 diff (99.7 %id) |
TI_57173816 | | .vi-u | 966 to 1333 | 342 to 714 | | tiling clone, | | 647/714 (90 %) | 17 diff (97.7 %id) |
AK310301 | testis | .vj | 1 to 984 | 2 to 985 | exact | tiling clone, | | 985/985 (100 %) | 0 diff (100 %id) |
DB022896 | testis | .vj | 1 to 558 | 2 to 559 | | capped | | 558/558 (100 %) | 1 diff (99.9 %id) |
DB047496 | testis | .vj | 1 to 558 | 2 to 559 | | capped | | 558/558 (100 %) | 0 diff (100 %id) |
BF973156 | leiomyosarcoma cell line, uterus | .vj | 4 to 636 | 1 to 646 | | | | 646/646 (100 %) | 24 diff (96.3 %id) |
BM564233 | brain, medulla | .vj | 51 to 355 | 1 to 305 | exact | | | 1015/1076 (94 %) | 44 diff (96.0 %id) |
BM007743 | Spleen | .vk-u | 1 to 673 | 1 to 672 | N9R K35E F40L | tiling clone, | | 672/687 (97 %) | 21 diff (97.0 %id) |
TI_59382976 | | .vk-u | 2 to 673 | 59 to 729 | N9R K35E F40L | | | 671/686 (97 %) | 21 diff (97.0 %id) |
AA351870 | brain | .vk-u | 633 to 836 | 1 to 204 | | tiling clone, | | 204/204 (100 %) | 0 diff (100 %id) |
CB147758 | Liver | .vl | 1 to 375 | 1 to 375 | | tiling clone, | | 375/375 (100 %) | 5 diff (98.7 %id) |
AA628621 | | .vl | 152 to 675 | 522 to 4 | Y11L E13R W14V K15E Q16T ... | tiling clone, | | 519/527 (98 %) | 11 diff (98.0 %id) |
BG982114 | colon_normal | .vm-u | 1 to 429 | 429 to 1 | exact | tiling clone, | | 429/429 (100 %) | 6 diff (98.7 %id) |
CV375360 | marrow | .vm-u | 175 to 287 | 1 to 111 | | | | 111/111 (100 %) | 9 diff (91.9 %id) |
BF767993 | colon_normal | .vm-u | 373 to 603 | 1 to 231 | | tiling clone, | | 231/231 (100 %) | 6 diff (97.5 %id) |
BP219666 | caudate nucleus | .vn-u | 1 to 603 | 1 to 603 | exact | tiling clone, | | 603/603 (100 %) | 1 diff (99.9 %id) |
AA701643 | liver and spleen | .vo-u | 1 to 543 | 543 to 1 | exact | tiling clone, | | 543/543 (100 %) | 1 diff (99.9 %id) |
AI033306 | liver and spleen | .vo-u | 157 to 543 | 386 to 1 | V33S S34P Q35S P37L Y39I ... | | | 386/386 (100 %) | 1 diff (99.8 %id) |
AW444885 | | .vo-u | 245 to 559 | 316 to 1 | L52V | tiling clone, | | 316/325 (97 %) | 4 diff (98.8 %id) |
BF893957 | marrow | .vp-u | 1 to 439 | 9 to 449 | S2P I12Y L13P D14G R15S ... | tiling clone, | | 441/449 (98 %) | 6 diff (98.7 %id) |
BF804801 | colon_ins | .vp-u | 32 to 346 | 340 to 26 | | tiling clone, | Submitted on the opposite strand | 315/340 (92 %) | 0 diff (100 %id) |
BQ330541 | lung_tumor | .vq-u | 1 to 415 | 1 to 415 | P7C F13Y S16Y P18G L19W ... | tiling clone, | | 415/415 (100 %) | 14 diff (96.7 %id) |
BG981281 | colon_normal | .vr-u | 1 to 410 | 1 to 412 | T2I F3L A4C F5L R6P ... | tiling clone, | | 412/412 (100 %) | 8 diff (98.1 %id) |
BF895228 | marrow | .vr-u | 104 to 273 | 1 to 169 | | tiling clone, | | 169/169 (100 %) | 2 diff (98.9 %id) |
BI003250 | head_normal | .vs | 1 to 271 | 270 to 1 | exact | tiling clone, | | 270/270 (100 %) | 1 diff (99.7 %id) |
TI_2194697024 | | Gene STARD10andARAP1, variant not shown | | | | | Submitted on the opposite strand, submitted on the opposite strand | | |
BF767507 | colon_normal | Gene STARD10andARAP1, variant not shown | | | | | | | |
R16359 | whole brain | Gene STARD10andARAP1, variant not shown | | | | | | | |
BI832405 | brain, medulla | Gene STARD10andARAP1, variant not shown | | | | available from MGC, | | | |
TI_57172889 | | Gene STARD10andARAP1, variant not shown | | | | | | | |
? | Gene Summary |
Gene on genome |
mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf-u, .vg-u, .vh, .vi-u, .vj, .vk-u, .vl, .vm-u, .vn-u, .vo-u, .vp-u, .vq-u, .vr-u, .vs |
Alternative mRNAs features, proteins, introns, exons, sequences |
Expression Tissue |
Function, regulation, related genes CI |
To mine knowledge about the gene, please click the 'Gene Summary' or the 'Function, regulation, related genes ' tab at the top of the page. The 'Gene Summary' page includes all we learnt about the gene, functional annotations of neighboring genes, maps, links to other sites and the bibliography. The 'Function, regulation, related genes ' page includes Diseases (D), Pathways, GO annotations, conserved domains (C), interactions (I) reference into function, and pointers to all genes with the same functional annotation.
To compare alternative variants, their summarized annotations, predicted proteins, introns and exons, or to access any sequence, click the 'Alternative mRNAs features' tab. To see a specific mRNA variant diagram, sequence and annotation, click the variant name in the 'mRNA' tab. To examine expression data from all cDNAs clustered in this gene by AceView, click the 'Expression tissue'.
If you know more about this gene, or found errors, please share your knowledge. Thank you !